{"id":2705,"date":"2020-11-06T15:54:47","date_gmt":"2020-11-06T15:54:47","guid":{"rendered":"https:\/\/cdafound.org\/?page_id=2705"},"modified":"2026-05-15T07:14:00","modified_gmt":"2026-05-15T07:14:00","slug":"publications","status":"publish","type":"page","link":"https:\/\/cdafound.org\/es\/publications\/","title":{"rendered":"Publicaciones"},"content":{"rendered":"<div class=\"wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link wp-element-button\" href=\"mailto:requestdata@cdafound.org\" target=\"_blank\" rel=\"noreferrer noopener\">Solicitar publicaci\u00f3n<\/a><\/div>\n<\/div>\n\n\n\n<hr class=\"wp-block-separator has-css-opacity is-style-wide\"\/>\n\n\n<!-- Gridbuilder \u1d42\u1d3e Plugin (https:\/\/wpgridbuilder.com) -->\n<div class=\"wp-grid-builder wpgb-grid-2 publications-grid-2\" data-options=\"{&quot;id&quot;:2,&quot;type&quot;:&quot;masonry&quot;,&quot;source&quot;:&quot;post_type&quot;,&quot;loader&quot;:true,&quot;layout&quot;:&quot;vertical&quot;,&quot;reveal&quot;:1,&quot;isMainQuery&quot;:false,&quot;lazyLoad&quot;:false,&quot;cardSizes&quot;:{&quot;9999&quot;:{&quot;columns&quot;:3,&quot;height&quot;:340,&quot;gutter&quot;:30,&quot;ratio&quot;:&quot;1.00000&quot;},&quot;959&quot;:{&quot;columns&quot;:2,&quot;height&quot;:340,&quot;gutter&quot;:30,&quot;ratio&quot;:&quot;1.00000&quot;},&quot;639&quot;:{&quot;columns&quot;:2,&quot;height&quot;:340,&quot;gutter&quot;:0,&quot;ratio&quot;:&quot;1.00000&quot;}},&quot;fitRows&quot;:true,&quot;equalRows&quot;:0,&quot;equalColumns&quot;:true,&quot;fillLastRow&quot;:0,&quot;centerLastRow&quot;:0,&quot;horizontalOrder&quot;:true,&quot;fullWidth&quot;:false,&quot;transitionDelay&quot;:100,&quot;gallerySlideshow&quot;:false,&quot;rowsNumber&quot;:1,&quot;slideAlign&quot;:&quot;left&quot;,&quot;groupCells&quot;:1,&quot;draggable&quot;:true,&quot;initialIndex&quot;:0,&quot;contain&quot;:false,&quot;freeScroll&quot;:false,&quot;freeFriction&quot;:&quot;0.075&quot;,&quot;friction&quot;:&quot;0.285&quot;,&quot;attraction&quot;:&quot;0.025&quot;,&quot;autoPlay&quot;:0,&quot;pageDotAriaLabel&quot;:&quot;Page dot %d&quot;,&quot;isPreview&quot;:false,&quot;isGutenberg&quot;:false,&quot;rightToLeft&quot;:false}\"><div class=\"wpgb-svg-icons\" hidden>\n\t<svg viewbox=\"0 0 120 24\" width=\"0\" height=\"0\">\n\t<defs>\n        <polygon id=\"wpgb-star-svg\" points=\"12 2.5 15.1 8.8 22 9.8 17 14.6 18.2 21.5 12 18.3 5.8 21.5 7 14.6 2 9.8 8.9 8.8\"><\/polygon>\n    <\/defs>\n    <symbol id=\"wpgb-rating-stars-svg\">\n        <use xlink:href=\"#wpgb-star-svg\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"24\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"48\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"72\"><\/use>\n        <use xlink:href=\"#wpgb-star-svg\" x=\"96\"><\/use>\n    <\/symbol>\n<\/svg>\n<\/div>\n<div class=\"wpgb-wrapper\">\n\t<div class=\"wpgb-main\">\n\t<div class=\"wpgb-area wpgb-area-top-1\">\n\t<div class=\"wpgb-facet wpgb-loading wpgb-facet-8\" data-facet=\"8\" data-grid=\"2\"><\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-4\" data-facet=\"4\" data-grid=\"2\"><\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-2\" data-facet=\"2\" data-grid=\"2\"><\/div><div class=\"wpgb-facet wpgb-loading wpgb-facet-7\" data-facet=\"7\" data-grid=\"2\"><\/div><\/div>\n<div class=\"wpgb-layout\">\n\t<div class=\"wpgb-viewport\">\n\t\t<div class=\"wpgb-masonry\">\n\t\t\t<article class=\"wpgb-card wpgb-card-7 wpgb-post-9222 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"2762\">control de enfermedades infecciosas<\/span><span class=\"wpgb-block-term\" data-id=\"2765\">Vinculaci\u00f3n con la atenci\u00f3n m\u00e9dica<\/span><span class=\"wpgb-block-term\" data-id=\"2766\">Modelos de atenci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"2763\">Escucha<\/span><span class=\"wpgb-block-term\" data-id=\"2764\">Prevenci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"2767\">Pruebas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2026-05-25T20:55:00+00:00\">25 de mayo de 2026<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/from-targets-to-real-world-impact-a-review-of-models-of-care-for-chronic-hbv-and-hcv-in-europe\/\">De los objetivos al impacto en el mundo real: una revisi\u00f3n de los modelos de atenci\u00f3n para la hepatitis B cr\u00f3nica y la hepatitis C en Europa.<\/a><\/h3><p class=\"wpgb-block-5\">El virus de la hepatitis B (VHB) y el virus de la hepatitis C (VHC) siguen siendo amenazas para la salud p\u00fablica en la regi\u00f3n europea de la OMS, donde se estima que 29 millones de personas viven con una infecci\u00f3n cr\u00f3nica y las muertes relacionadas con la hepatitis viral superan ahora a...<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/from-targets-to-real-world-impact-a-review-of-models-of-care-for-chronic-hbv-and-hcv-in-europe\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9226 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"59\">Carga de enfermedad<\/span><span class=\"wpgb-block-term\" data-id=\"2701\">Uni\u00f3n Europea<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2026-05-09T21:03:00+00:00\">9 de mayo de 2026<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/implementing-sustainable-liver-health-in-europe-a-second-easl-lancet-commission\/\">Implementaci\u00f3n de pr\u00e1cticas sostenibles de salud hep\u00e1tica en Europa: Segunda Comisi\u00f3n EASL-Lancet<\/a><\/h3><p class=\"wpgb-block-5\">En diciembre de 2021, la Comisi\u00f3n Lancet de la Asociaci\u00f3n Europea para el Estudio del H\u00edgado (EASL) sobre enfermedades hep\u00e1ticas en Europa public\u00f3 su primer informe, que puso de manifiesto un alarmante aumento de la mortalidad relacionada con el h\u00edgado en muchos pa\u00edses europeos. El\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/implementing-sustainable-liver-health-in-europe-a-second-easl-lancet-commission\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9160 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 500&#215;500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2026-03-24T06:08:00+00:00\">24 de marzo de 2026<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-burden-of-chronic-hepatitis-b-and-c-in-2022-and-progress-towards-elimination-a-global-report\/\">La carga de la hepatitis B y C cr\u00f3nica en 2022 y los avances hacia su eliminaci\u00f3n: un informe mundial.<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La OMS ha trabajado estrechamente con los Estados miembros para establecer objetivos de referencia, supervisar los progresos y las deficiencias, y desarrollar una estrategia para lograr la eliminaci\u00f3n de la hepatitis v\u00edrica como amenaza para la salud p\u00fablica para 2030\u2026.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-burden-of-chronic-hepatitis-b-and-c-in-2022-and-progress-towards-elimination-a-global-report\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9163 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2026\/01\/ScienceDirect.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"ScienceDirect\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2026\/01\/ScienceDirect.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2026\/01\/ScienceDirect.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"2748\">Desarrollo de f\u00e1rmacos<\/span><span class=\"wpgb-block-term\" data-id=\"2747\">EMA<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"58\">HDV<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2026-01-01T06:12:00+00:00\">1 de enero de 2026<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/bulevirtide-for-chronic-hepatitis-delta-from-clinical-trials-to-real-life-data-an-expert-opinion-report\/\">Bulevirtida para la hepatitis delta cr\u00f3nica: de los ensayos cl\u00ednicos a los datos de la vida real: un informe de opini\u00f3n de expertos.<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El virus de la hepatitis D (VHD) es un virus de ARN peque\u00f1o que requiere el ant\u00edgeno de superficie de la hepatitis B (HBsAg) para su envoltura. Se han descrito ocho genotipos con m\u00e1s de 80 homolog\u00edas de secuencia % y muchos subgenotipos\u2026.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/bulevirtide-for-chronic-hepatitis-delta-from-clinical-trials-to-real-life-data-an-expert-opinion-report\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9142 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"2693\">Inmigraci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"2694\">Predominio<\/span><span class=\"wpgb-block-term\" data-id=\"2695\">Estados Unidos<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-12-02T05:32:00+00:00\">2 de diciembre de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-current-burden-of-hepatitis-b-in-the-united-states-a-state-territorial-and-county-modelling-analysis\/\">La carga actual de la hepatitis B en los Estados Unidos: un an\u00e1lisis de modelos a nivel estatal, territorial y de condado.<\/a><\/h3><p class=\"wpgb-block-5\">Las estimaciones precisas de la prevalencia del virus de la hepatitis B (VHB) cr\u00f3nico en los Estados Unidos (EE. UU.) son necesarias para que los responsables pol\u00edticos y las organizaciones comunitarias tomen decisiones informadas sobre la asignaci\u00f3n de recursos para trabajar\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-current-burden-of-hepatitis-b-in-the-united-states-a-state-territorial-and-county-modelling-analysis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9151 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/11\/IntechOpen.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"IntechOpen\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2025\/11\/IntechOpen.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/11\/IntechOpen.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"2710\">Vacunaci\u00f3n contra el VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"2711\">Tratamiento de la hepatitis C<\/span><span class=\"wpgb-block-term\" data-id=\"2709\">Mortalidad relacionada con el h\u00edgado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-11-26T05:47:00+00:00\">26 de noviembre de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-progress-toward-viral-hepatitis-elimination\/\">Progreso mundial hacia la eliminaci\u00f3n de la hepatitis viral<\/a><\/h3><p class=\"wpgb-block-5\">A pesar de los compromisos mundiales para eliminar la hepatitis viral para 2030, el progreso sigue siendo desigual. El Observatorio Polaris recopila datos de m\u00e1s de 170 pa\u00edses para evaluar la eliminaci\u00f3n de la hepatitis B (VHB) y C (VHC). Si bien algunas naciones han logrado\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-progress-toward-viral-hepatitis-elimination\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9133 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"2686\">Transmisi\u00f3n de madre a hijo<\/span><span class=\"wpgb-block-term\" data-id=\"2687\">Profilaxis con tenofovir<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-11-19T03:17:00+00:00\">19 de noviembre de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modelling-micro-elimination-third-trimester-tenofovir-prophylaxis-for-perinatal-transmission-of-hepatitis-b-in-the-remote-dolpa-district-of-nepal\/\">Modelizaci\u00f3n de la microeliminaci\u00f3n: profilaxis con tenofovir en el tercer trimestre para la transmisi\u00f3n perinatal de la hepatitis B en el remoto distrito de Dolpa, Nepal.<\/a><\/h3><p class=\"wpgb-block-5\">La prevalencia de la hepatitis B (VHB) es muy alta en mujeres embarazadas en el distrito de Dolpa, Nepal, una regi\u00f3n caracterizada por un paisaje geogr\u00e1fico remoto y una baja cobertura de vacunaci\u00f3n. Mediante modelos matem\u00e1ticos, evaluamos el impacto\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modelling-micro-elimination-third-trimester-tenofovir-prophylaxis-for-perinatal-transmission-of-hepatitis-b-in-the-remote-dolpa-district-of-nepal\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9139 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/09\/NPJ-Gut-and-Liver.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"NPJ Gut and Liver\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2025\/09\/NPJ-Gut-and-Liver.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2025\/09\/NPJ-Gut-and-Liver.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-09-03T03:45:00+00:00\">3 de septiembre de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/closing-the-gap-in-hcv-care-strategic-collaboration-between-industry-academic-community-and-nonprofit-researchers\/\">Cerrando la brecha en la atenci\u00f3n de la hepatitis C: colaboraci\u00f3n estrat\u00e9gica entre investigadores de la industria, el \u00e1mbito acad\u00e9mico, la comunidad y las organizaciones sin fines de lucro.<\/a><\/h3><p class=\"wpgb-block-5\">Se necesita mayor financiaci\u00f3n para la investigaci\u00f3n y la atenci\u00f3n del virus de la hepatitis C (VHC) con el fin de respaldar programas eficaces para las comunidades vulnerables y alcanzar los objetivos de la OMS para 2030 en materia de eliminaci\u00f3n del VHC. Colaboraciones estrat\u00e9gicas entre la industria y otros sectores\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/closing-the-gap-in-hcv-care-strategic-collaboration-between-industry-academic-community-and-nonprofit-researchers\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9145 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"2677\">Epidemiolog\u00eda<\/span><span class=\"wpgb-block-term\" data-id=\"2701\">Uni\u00f3n Europea<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"2693\">Inmigraci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"2694\">Predominio<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-09-02T05:36:00+00:00\">2 de septiembre de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimating-the-impact-of-displacement-from-ukraine-on-hbv-and-hcv-prevalence-among-migrants-in-the-european-union-2024-a-modeling-study\/\">Estimaci\u00f3n del impacto del desplazamiento desde Ucrania en la prevalencia del VHB y el VHC entre los migrantes en la Uni\u00f3n Europea, 2024: Un estudio de modelizaci\u00f3n<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes En pa\u00edses con baja carga basal de los virus de la hepatitis B y C (VHB, VHC), los altos niveles de migraci\u00f3n pueden afectar la carga de hepatitis viral. El cribado y el tratamiento de los migrantes requieren diferentes\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimating-the-impact-of-displacement-from-ukraine-on-hbv-and-hcv-prevalence-among-migrants-in-the-european-union-2024-a-modeling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9157 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"2729\">Editorial<\/span><span class=\"wpgb-block-term\" data-id=\"58\">HDV<\/span><span class=\"wpgb-block-term\" data-id=\"2728\">Enfermedad rara<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-07-01T05:57:00+00:00\">1 de julio de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-call-to-reclassify-the-delta-hepatitis-virus-as-an-orphan-disease\/\">Un llamamiento para reclasificar el virus de la hepatitis delta como enfermedad rara.<\/a><\/h3><p class=\"wpgb-block-5\">La infecci\u00f3n cr\u00f3nica por VHD se considera la forma m\u00e1s agresiva y grave de hepatitis viral, asociada a un mayor riesgo de cirrosis y c\u00e1ncer de h\u00edgado. Debido a la alta morbilidad y mortalidad, existe una clara\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-call-to-reclassify-the-delta-hepatitis-virus-as-an-orphan-disease\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9126 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Hepatology_500X500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"2688\">MASLD<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-07-01T02:04:00+00:00\">1 de julio de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-the-health-and-economic-impact-of-pharmacologic-therapies-for-masld-in-the-united-states\/\">Modelizaci\u00f3n del impacto sanitario y econ\u00f3mico de las terapias farmacol\u00f3gicas para la MASLD en los Estados Unidos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La enfermedad hep\u00e1tica esteat\u00f3sica asociada a la disfunci\u00f3n metab\u00f3lica (MASLD), la causa de enfermedad hep\u00e1tica cr\u00f3nica de m\u00e1s r\u00e1pido crecimiento y prevalencia, se asocia con costos sanitarios sustanciales. A medida que aumenta la carga de la enfermedad y los costos, la terapia farmacol\u00f3gica que detiene la MASLD\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-the-health-and-economic-impact-of-pharmacologic-therapies-for-masld-in-the-united-states\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9154 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Hepatology_500X500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"58\">HDV<\/span><span class=\"wpgb-block-term\" data-id=\"2712\">Observatorio Polaris<\/span><span class=\"wpgb-block-term\" data-id=\"2713\">Regiones<\/span><span class=\"wpgb-block-term\" data-id=\"2714\">Regiones de la OMS<\/span><span class=\"wpgb-block-term\" data-id=\"2715\">Regiones del Banco Mundial<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-02-03T05:52:00+00:00\">3 de febrero de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/number-of-people-treated-for-hepatitis-c-virus-infection-in-2014-2023-and-applicable-lessons-for-new-hbv-and-hdv-therapies\/\">N\u00famero de personas tratadas por infecci\u00f3n por el virus de la hepatitis C entre 2014 y 2023 y lecciones aplicables a las nuevas terapias contra el VHB y el VHD.<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos El a\u00f1o 2023 marc\u00f3 el d\u00e9cimo aniversario del lanzamiento de los antivirales de acci\u00f3n directa (AAD) para el tratamiento del virus de la hepatitis C (VHC). El seguimiento de las tendencias de tratamiento del VHC por pa\u00eds, regi\u00f3n y a nivel mundial\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/number-of-people-treated-for-hepatitis-c-virus-infection-in-2014-2023-and-applicable-lessons-for-new-hbv-and-hdv-therapies\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9130 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"2677\">Epidemiolog\u00eda<\/span><span class=\"wpgb-block-term\" data-id=\"2678\">Etiop\u00eda<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"2680\">Dosis universal al nacer<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2025-01-16T03:08:00+00:00\">16 de enero de 2025<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-disease-and-economic-burden-of-hbv-and-hcvin-ethiopia\/\">La carga econ\u00f3mica y de morbilidad del VHB y el VHC en Etiop\u00eda<\/a><\/h3><p class=\"wpgb-block-5\">Como segundo pa\u00eds m\u00e1s poblado de \u00c1frica, Etiop\u00eda necesita medidas de salud p\u00fablica para controlar las enfermedades que afectan a su poblaci\u00f3n. El objetivo de este estudio es analizar la carga de morbilidad del VHB y el VHC, mientras que\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-disease-and-economic-burden-of-hbv-and-hcvin-ethiopia\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-6406 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"59\">Carga de enfermedad<\/span><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"60\">Elegibilidad<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><span class=\"wpgb-block-term\" data-id=\"61\">Tratamiento<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2024-05-09T18:22:36+00:00\">mayo 9, 2024<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-economic-argument-for-hepatitis-b-treatment-simplification-and-expansion\/\">El argumento econ\u00f3mico a favor de la simplificaci\u00f3n y expansi\u00f3n del tratamiento de la hepatitis B<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Un componente de las decisiones relativas a la simplificaci\u00f3n y expansi\u00f3n del tratamiento del virus de la hepatitis B (VHB) es la perspectiva econ\u00f3mica. Se revis\u00f3 la literatura en busca de estudios que proporcionen estimaciones del impacto econ\u00f3mico de la simplificaci\u00f3n y expansi\u00f3n del tratamiento\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-economic-argument-for-hepatitis-b-treatment-simplification-and-expansion\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-6391 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"BMC_Gastroenterology_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2024-04-16T16:00:53+00:00\">16 de abril de 2024<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-screening-in-lithuania-first-year-results-and-scenarios-for-achieving-who-elimination-targets\/\">Detecci\u00f3n de la hepatitis C en Lituania: resultados del primer a\u00f1o y escenarios para alcanzar los objetivos de eliminaci\u00f3n de la OMS<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La Organizaci\u00f3n Mundial de la Salud (OMS) ha establecido un conjunto de objetivos para lograr la eliminaci\u00f3n de la hepatitis C para 2030. En mayo de 2022, las autoridades sanitarias lituanas iniciaron un programa de detecci\u00f3n del virus de la hepatitis C (VHC) para comenzar\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-screening-in-lithuania-first-year-results-and-scenarios-for-achieving-who-elimination-targets\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-9148 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/AASLD_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2024-02-25T05:43:00+00:00\">25 de febrero de 2024<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-hbv-disease-burden-and-current-care-gaps\/\">Carga mundial de la enfermedad por VHB y deficiencias actuales en la atenci\u00f3n m\u00e9dica.<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2022, publicamos un an\u00e1lisis global actualizado del VHB que tambi\u00e9n describ\u00eda la incertidumbre en las estimaciones nacionales. Podemos estimar la carga de la enfermedad en 2023, la cascada de atenci\u00f3n y el n\u00famero de pa\u00edses\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-hbv-disease-burden-and-current-care-gaps\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-6212 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 500&#215;500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-12-15T06:59:21+00:00\">diciembre 15, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-prevalence-cascade-of-care-and-prophylaxis-coverage-of-hepatitis-b-in-2022-a-modelling-study\/\">Prevalencia global, cascada de atenci\u00f3n y cobertura de profilaxis de la hepatitis B en 2022: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La Asamblea Mundial de la Salud de 2016 aprob\u00f3 la eliminaci\u00f3n de la infecci\u00f3n por el virus de la hepatitis B (VHB) como amenaza para la salud p\u00fablica para 2030; las terapias y medidas de profilaxis existentes hacen que dicha eliminaci\u00f3n sea factible, incluso en ausencia\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-prevalence-cascade-of-care-and-prophylaxis-coverage-of-hepatitis-b-in-2022-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-6209 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Hepatology_500X500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"58\">HDV<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-12-15T06:49:58+00:00\">diciembre 15, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/adjusted-estimate-of-the-prevalence-of-hepatitis-delta-virus-in-25-countries-and-territories\/\">Estimaci\u00f3n ajustada de la prevalencia del virus de la hepatitis delta en 25 pa\u00edses y territorios<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Existe una gran incertidumbre en torno a la prevalencia del virus de la hepatitis delta entre las personas que viven con el virus de la hepatitis B a nivel de poblaci\u00f3n. En este estudio, nuestro objetivo fue comprender mejor la\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/adjusted-estimate-of-the-prevalence-of-hepatitis-delta-virus-in-25-countries-and-territories\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5877 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:110.34%\" viewbox=\"0 0 145 160\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"elsevier\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png\" alt=\"\" height=\"160\" width=\"145\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-06-01T15:19:00+00:00\">1 de junio de 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-impact-of-immigration-on-hepatitis-b-burden-in-the-united-states-a-modelling-study\/\">El impacto de la inmigraci\u00f3n en la carga de hepatitis B en los Estados Unidos: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La Asamblea Mundial de la Salud de 2016 aprob\u00f3 la eliminaci\u00f3n de las infecciones por el virus de la hepatitis B (VHB) para 2030. Sin embargo, la prevalencia del VHB en los pa\u00edses occidentales, donde la prevalencia hist\u00f3rica es baja y est\u00e1 muy afectada por la inmigraci\u00f3n\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-impact-of-immigration-on-hepatitis-b-burden-in-the-united-states-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5874 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-06-01T15:16:00+00:00\">1 de junio de 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-of-treating-all-hepatitis-b-positive-individuals-in-the-united-states\/\">Costo-efectividad de tratar a todas las personas con hepatitis B positivas en los Estados Unidos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis B (VHB) es una de las principales causas de enfermedad hep\u00e1tica y mortalidad relacionada a nivel mundial. Sin embargo, la mayor\u00eda de las personas infectadas en los Estados Unidos siguen sin ser diagnosticadas ni tratadas.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-of-treating-all-hepatitis-b-positive-individuals-in-the-united-states\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5865 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Swiss_Medical_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-05-06T15:06:00+00:00\">mayo 6, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-current-and-future-burden-of-hepatitis-b-in-switzerland-a-modelling-study\/\">La carga actual y futura de la hepatitis B en Suiza: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por hepatitis B (definida como la detecci\u00f3n sostenida de la prote\u00edna del ant\u00edgeno de superficie del virus de la hepatitis B en el suero) es una de las principales causas de cirrosis, carcinoma hepatocelular y muertes relacionadas con el h\u00edgado. Un an\u00e1lisis de la situaci\u00f3n realizado\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-current-and-future-burden-of-hepatitis-b-in-switzerland-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5843 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:72.47%\" viewbox=\"0 0 396 287\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/Screenshot-2023-06-16-103831.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Screenshot 2023-06-16 103831\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/Screenshot-2023-06-16-103831.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/Screenshot-2023-06-16-103831.png\" alt=\"\" height=\"287\" width=\"396\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-04-18T10:36:00+00:00\">abril 18, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/evidence-for-benefits-of-early-treatment-initiation-for-chronic-hepatitis-b\/\">Evidencia de los beneficios del inicio temprano del tratamiento para la hepatitis B cr\u00f3nica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La hepatitis B cr\u00f3nica (HBC) es la causa m\u00e1s frecuente de carcinoma hepatocelular (CHC) en todo el mundo. El tratamiento antiviral reduce el riesgo de CHC y la mortalidad; sin embargo, a nivel mundial en 2019, solo el 2,2% de los pacientes con CHB recibieron tratamiento\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/evidence-for-benefits-of-early-treatment-initiation-for-chronic-hepatitis-b\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5831 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-04-18T00:46:00+00:00\">abril 18, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-reporting-of-progress-towards-elimination-of-hepatitis-b-and-hepatitis-c\/\">Impactos del Programa Nacional Egipcio de Detecci\u00f3n y Tratamiento de la Hepatitis C Viral: Un Modelo de Costo-Efectividad<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Egipto sol\u00eda tener una de las prevalencias m\u00e1s altas de infecci\u00f3n por VHC en todo el mundo. El Ministerio de Salud egipcio lanz\u00f3 una campa\u00f1a nacional para la detecci\u00f3n y el manejo del VHC con el fin de reducir su incidencia.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-reporting-of-progress-towards-elimination-of-hepatitis-b-and-hepatitis-c\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5847 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-03-15T14:41:00+00:00\">15 de marzo de 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-payer-license-agreement-or-netflix-model-for-hepatitis-c-virus-therapies-enables-universal-treatment-access-lowers-costs-and-incentivizes-innovation-and-competition\/\">El Acuerdo de Licencia de Pagador, o \u201cModelo Netflix\u201d, para las Terapias contra el Virus de la Hepatitis C Permite el Acceso Universal al Tratamiento, Reduce los Costos e Incentiva la Innovaci\u00f3n y la Competencia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Los altos precios unitarios de los tratamientos limitan el acceso. En el caso de epidemias como la del virus de la hepatitis C (VHC), la reducci\u00f3n del acceso al tratamiento aumenta la prevalencia y la incidencia, lo que hace que la enfermedad infecciosa sea cada vez m\u00e1s dif\u00edcil de controlar. El objetivo de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-payer-license-agreement-or-netflix-model-for-hepatitis-c-virus-therapies-enables-universal-treatment-access-lowers-costs-and-incentivizes-innovation-and-competition\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5852 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-03-08T14:46:00+00:00\">8 de marzo de 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-and-economic-investment-to-eliminate-chronic-hepatitis-c-in-mexico\/\">Costo-efectividad e inversi\u00f3n econ\u00f3mica para eliminar la hepatitis C cr\u00f3nica en M\u00e9xico<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En julio de 2020, el gobierno mexicano inici\u00f3 el Programa Nacional para la Eliminaci\u00f3n de la Hepatitis C (VHC) mediante un acuerdo de adquisici\u00f3n, asegurando el acceso universal y gratuito a la detecci\u00f3n, diagn\u00f3stico y tratamiento del VHC para 2020-2022. Este an\u00e1lisis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-and-economic-investment-to-eliminate-chronic-hepatitis-c-in-mexico\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5887 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/idsa-500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"idsa-500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/idsa-500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/idsa-500.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"11\" style=\"color:#00d084\">Pedi\u00e1trico<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-01-31T15:32:00+00:00\">enero 31, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/now-is-the-time-to-scale-up-birth-dose-hepatitis-b-vaccine-in-low-and-middle-income-countries\/\">Ha llegado el momento de aumentar la dosis de la vacuna contra la hepatitis B al nacer en los pa\u00edses de ingresos bajos y medianos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Menos de la mitad de los beb\u00e9s del mundo tienen acceso a la dosis de nacimiento de la vacuna contra la hepatitis B (VHB), que previene la transmisi\u00f3n de madre a hijo del VHB y el c\u00e1ncer de h\u00edgado posterior. Ahora es el momento de ampliar\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/now-is-the-time-to-scale-up-birth-dose-hepatitis-b-vaccine-in-low-and-middle-income-countries\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5856 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-01-17T14:52:00+00:00\">enero 17, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-prevalence-and-elimination-planning-in-pakistan-a-bottom-up-approach-accounting-for-provincial-variation\/\">Planificaci\u00f3n de la prevalencia y eliminaci\u00f3n de la hepatitis C en Pakist\u00e1n, un enfoque de abajo hacia arriba que tiene en cuenta la variaci\u00f3n provincial<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En Pakist\u00e1n, se han producido cambios sustanciales en la programaci\u00f3n y el tratamiento del virus de la hepatitis C (VHC) desde que la encuesta serol\u00f3gica nacional de 2008 estim\u00f3 una prevalencia de anticuerpos anti-VHC de 4,8%. En ausencia de un estudio nacional actualizado, este an\u00e1lisis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-prevalence-and-elimination-planning-in-pakistan-a-bottom-up-approach-accounting-for-provincial-variation\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5807 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"CMAJ_Open_06.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"11\" style=\"color:#00d084\">Pedi\u00e1trico<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-01-10T23:41:00+00:00\">enero 10, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-modelling-of-birth-and-infant-dose-vaccination-against-hepatitis-b-virus-in-ontario-from-2020-to-2050\/\">Modelado de rentabilidad de la vacunaci\u00f3n de dosis infantil y de nacimiento contra el virus de la hepatitis B en Ontario de 2020 a 2050<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La Organizaci\u00f3n Mundial de la Salud recomienda la vacunaci\u00f3n universal contra el virus de la hepatitis B (VHB) al nacer, pero solo tres provincias y territorios de Canad\u00e1 proporcionan la vacunaci\u00f3n al nacer, y los ni\u00f1os nacidos en Canad\u00e1 en Ontario est\u00e1n contrayendo el VHB\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/cost-effectiveness-modelling-of-birth-and-infant-dose-vaccination-against-hepatitis-b-virus-in-ontario-from-2020-to-2050\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5863 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-01-06T15:03:00+00:00\">enero 6, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/viral-hepatitis-elimination-challenges-in-low-and-middle-income-countries-uzbekistan-hepatitis-elimination-program-uhep\/\">Desaf\u00edos de la eliminaci\u00f3n de la hepatitis viral en pa\u00edses de ingresos bajos y medianos: Programa de eliminaci\u00f3n de la hepatitis de Uzbekist\u00e1n (UHEP)<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por los virus de la hepatitis B y C (VHB y VHC) es una de las principales causas de la enfermedad hep\u00e1tica y de la mortalidad relacionada con el h\u00edgado en Uzbekist\u00e1n. Es necesario demostrar la viabilidad de un diagn\u00f3stico simplificado a gran escala\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/viral-hepatitis-elimination-challenges-in-low-and-middle-income-countries-uzbekistan-hepatitis-elimination-program-uhep\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5816 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:110.34%\" viewbox=\"0 0 145 160\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"elsevier\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2023\/06\/elsevier.png\" alt=\"\" height=\"160\" width=\"145\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"55\">COVID-19<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2023-01-01T00:13:00+00:00\">enero 1, 2023<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-hcv-elimination-recovery-following-the-covid-19-pandemic-in-the-united-states-pathways-to-regain-progress-2\/\">Modelado de la recuperaci\u00f3n de la eliminaci\u00f3n del VHC despu\u00e9s de la pandemia de COVID-19 en los Estados Unidos: caminos para recuperar el progreso<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2019, Estados Unidos no estaba en v\u00edas de alcanzar los objetivos de eliminaci\u00f3n debido a la creciente incidencia y las barreras de tratamiento. En 2020, la pandemia de COVID-19 interrumpi\u00f3 los servicios de atenci\u00f3n del VHC a nivel mundial y en\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-hcv-elimination-recovery-following-the-covid-19-pandemic-in-the-united-states-pathways-to-regain-progress-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5826 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 500&#215;500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"11\" style=\"color:#00d084\">Pedi\u00e1trico<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-12-05T00:34:00+00:00\">5 de diciembre de 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/an-open-letter-to-gavi-hepatitis-b-birth-dose-vaccine-cant-wait\/\">Una carta abierta a Gavi: La dosis de vacuna al nacer contra la hepatitis B no puede esperar<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Cada a\u00f1o, m\u00e1s de un cuarto de mill\u00f3n de ni\u00f1os contraen hepatitis B cr\u00f3nica al nacer. Decenas de miles morir\u00e1n prematuramente a causa de c\u00e1ncer de h\u00edgado u otras formas de enfermedad hep\u00e1tica.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/an-open-letter-to-gavi-hepatitis-b-birth-dose-vaccine-cant-wait\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5893 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-10-05T15:42:00+00:00\">octubre 5, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/securing-wider-eu-commitment-to-the-elimination-of-hepatitis-c-virus\/\">Asegurar un compromiso m\u00e1s amplio de la UE para la eliminaci\u00f3n del virus de la hepatitis C<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2016, la Asociaci\u00f3n de Pol\u00edticas P\u00fablicas sobre Hepatitis B y C (HepBCPPA) reuni\u00f3 a todos los principales interesados en el campo del virus de la hepatitis C (VHC) para lanzar el ahora hist\u00f3rico Manifiesto de Eliminaci\u00f3n del VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/securing-wider-eu-commitment-to-the-elimination-of-hepatitis-c-virus\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5881 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"55\">COVID-19<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-08-12T15:25:00+00:00\">agosto 12, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modelling-the-microelimination-of-chronic-hepatitis-c-in-the-canton-of-bern-switzerland-reaching-the-swiss-hepatitis-strategy-goals-despite-the-impact-of-the-covid-19-pandemic\/\">Modelado de la microeliminaci\u00f3n de la hepatitis C cr\u00f3nica en el cant\u00f3n de Berna, Suiza: Alcanzar los objetivos de la estrategia suiza contra la hepatitis a pesar del impacto de la pandemia de COVID 19<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Desde 2014, la Estrategia Suiza contra la Hepatitis (SHS) tiene como objetivo la eliminaci\u00f3n del virus de la hepatitis C (VHC) en Suiza. La epidemiolog\u00eda del VHC es diversa en los cantones suizos, por lo que las estrategias de detecci\u00f3n y tratamiento a nivel cantonal deber\u00edan\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modelling-the-microelimination-of-chronic-hepatitis-c-in-the-canton-of-bern-switzerland-reaching-the-swiss-hepatitis-strategy-goals-despite-the-impact-of-the-covid-19-pandemic\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5839 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/05\/apt-500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"apt-500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/05\/apt-500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/05\/apt-500.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-05-25T01:00:00+00:00\">mayo 25, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/impact-of-expanding-hepatitis-b-treatment-guidelines-a-modelling-and-economic-impact-analysis\/\">Impacto de la expansi\u00f3n de las pautas de tratamiento de la hepatitis B: un modelo y un an\u00e1lisis del impacto econ\u00f3mico<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El tratamiento antiviral en pacientes con hepatitis B cr\u00f3nica (HBC) puede reducir el riesgo de carcinoma hepatocelular (CHC) y muerte. Sin embargo, solo el 2,2% de los pacientes con HBC reciben tratamiento antiviral a nivel mundial. La complejidad y rigurosidad de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/impact-of-expanding-hepatitis-b-treatment-guidelines-a-modelling-and-economic-impact-analysis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5501 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-04-29T15:03:42+00:00\">abril 29, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/opportunistic-co-screening-for-hcv-and-covid-19-relatedservices-a-creative-response-with-a-need-for-thoughtful-reflection\/\">Detecci\u00f3n conjunta oportunista de servicios relacionados con el VHC y la COVID-19: una respuesta creativa con la necesidad de una reflexi\u00f3n reflexiva<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En un momento en que se puede lograr la eliminaci\u00f3n del virus de la hepatitis C mediante AAD en casi todos los pacientes infectados, el control de la carga de infecci\u00f3n global es un objetivo al alcance, incluso si se logra la eliminaci\u00f3n del VHC por parte de la OMS\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/opportunistic-co-screening-for-hcv-and-covid-19-relatedservices-a-creative-response-with-a-need-for-thoughtful-reflection\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5822 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"BMC_Gastroenterology_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-04-22T00:25:00+00:00\">abril 22, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/ten-years-countdown-to-hepatitis-c-elimination-in-belgium-a-mathematical-modeling-approach\/\">Cuenta regresiva de diez a\u00f1os para la eliminaci\u00f3n de la hepatitis C en B\u00e9lgica: un enfoque de modelado matem\u00e1tico<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) sigue siendo un problema de salud mundial. Por ello, la Organizaci\u00f3n Mundial de la Salud (OMS) ha establecido objetivos de eliminaci\u00f3n para 2030. Este estudio tiene como objetivo examinar la situaci\u00f3n\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/ten-years-countdown-to-hepatitis-c-elimination-in-belgium-a-mathematical-modeling-approach\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5884 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"55\">COVID-19<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-03-31T15:29:00+00:00\">marzo 31, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/updated-epidemiology-of-hepatitis-c-virus-infections-and-implications-for-hepatitis-c-virus-elimination-in-germany\/\">Epidemiolog\u00eda actualizada de las infecciones por el virus de la hepatitis C e implicaciones para la eliminaci\u00f3n del virus de la hepatitis C en Alemania<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2014 se realiz\u00f3 un an\u00e1lisis para evaluar la epidemiolog\u00eda y la carga de enfermedad del virus de la hepatitis C (VHC) en Alemania. Desde entonces, se han producido avances considerables en el manejo del VHC, como la implementaci\u00f3n de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/updated-epidemiology-of-hepatitis-c-virus-infections-and-implications-for-hepatitis-c-virus-elimination-in-germany\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5869 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/03\/sage-500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"sage-500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/03\/sage-500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/03\/sage-500.png\" alt=\"\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-03-04T15:11:00+00:00\">4 de marzo de 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/polaris-observatory-supporting-informed-decision-making-at-the-national-regional-and-global-levels-to-eliminate-viral-hepatitis\/\">Observatorio Polaris: apoyo a la toma de decisiones informada a nivel nacional, regional y mundial para eliminar la hepatitis viral<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se dispone de herramientas para eliminar las hepatitis B y C y, en 2016, la Asamblea Mundial de la Salud aprob\u00f3 la Estrategia mundial del sector de la salud para la hepatitis viral. Sin embargo, la adopci\u00f3n de programas de eliminaci\u00f3n de la hepatitis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/polaris-observatory-supporting-informed-decision-making-at-the-national-regional-and-global-levels-to-eliminate-viral-hepatitis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5434 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 500&#215;500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/02\/Lancet-500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2022-02-16T08:22:00+00:00\">febrero 16, 2022<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-change-in-hepatitis-c-virus-prevalence-and-cascade-of-care-between-2015-and-2020-a-modelling-study\/\">Cambio global en la prevalencia del virus de la hepatitis C y la cascada de atenci\u00f3n entre 2015 y 2020: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Desde la publicaci\u00f3n de los primeros objetivos mundiales de eliminaci\u00f3n de la hepatitis en 2016, y hasta que comenz\u00f3 la pandemia de COVID-19 a principios de 2020, muchos pa\u00edses y territorios estaban avanzando hacia la eliminaci\u00f3n del virus de la hepatitis C (VHC).<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-change-in-hepatitis-c-virus-prevalence-and-cascade-of-care-between-2015-and-2020-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5104 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-12-11T09:59:00+00:00\">11 de diciembre de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/progress-towards-achieving-viral-hepatitis-b-and-c-elimination-in-the-asia-and-pacific-region-results-from-modelling-and-global-reporting\/\">Progresos hacia la eliminaci\u00f3n de las hepatitis virales B y C en la regi\u00f3n de Asia y el Pac\u00edfico: resultados de la elaboraci\u00f3n de modelos y la presentaci\u00f3n de informes a nivel mundial<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2016, los pa\u00edses de Asia y el Pac\u00edfico aprobaron planes de acci\u00f3n para alcanzar los objetivos de eliminaci\u00f3n de la hepatitis viral establecidos en la Estrategia mundial del sector de la salud para la hepatitis viral 2016-2021. Examinamos el progreso de la regi\u00f3n mediante la elaboraci\u00f3n de modelos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/progress-towards-achieving-viral-hepatitis-b-and-c-elimination-in-the-asia-and-pacific-region-results-from-modelling-and-global-reporting\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5102 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Hepatology_500X500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/JOH_500X500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-12-01T09:38:00+00:00\">1 de diciembre de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-global-nafld-policy-review-and-preparedness-index-are-countries-ready-to-address-this-silent-public-health-challenge\/\">El \u00edndice de preparaci\u00f3n y revisi\u00f3n de pol\u00edticas globales de NAFLD: \u00bfEst\u00e1n los pa\u00edses listos para abordar este desaf\u00edo silencioso de salud p\u00fablica?<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La enfermedad del h\u00edgado graso no alcoh\u00f3lico (EHGNA) es una afecci\u00f3n hep\u00e1tica muy prevalente, aunque poco reconocida, que est\u00e1 estrechamente asociada con la obesidad y las enfermedades metab\u00f3licas. A pesar de que afecta a aproximadamente 1 de cada 4 adultos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-global-nafld-policy-review-and-preparedness-index-are-countries-ready-to-address-this-silent-public-health-challenge\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5106 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-11-27T10:16:00+00:00\">27 de noviembre de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hcv-disease-burden-and-population-segments-in-switzerland\/\">Carga de enfermedad por VHC y segmentos de poblaci\u00f3n en Suiza<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Suiza ha avanzado hacia la eliminaci\u00f3n del virus de la hepatitis C, pero a partir de 2019, la eliminaci\u00f3n no estaba garantizada. Sin embargo, el inter\u00e9s pol\u00edtico en la hepatitis viral ha ido en aumento. Buscamos desarrollar una mejor comprensi\u00f3n\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hcv-disease-burden-and-population-segments-in-switzerland\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5109 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/CGH_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Clinical Gastroenterology and Hepatology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/CGH_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/CGH_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"52\" style=\"color:#f78764\">Colangitis esclerosante primaria<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-08-30T10:23:00+00:00\">agosto 30, 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/epidemiology-natural-history-and-outcomes-of-primary-sclerosing-cholangitis-a-systematic-review-of-population-based-studies\/\">Epidemiolog\u00eda, historia natural y resultados de la colangitis esclerosante primaria: una revisi\u00f3n sistem\u00e1tica de estudios basados en la poblaci\u00f3n<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos El objetivo de este estudio fue cuantificar la epidemiolog\u00eda global de la colangitis esclerosante primaria (CEP), junto con la incidencia de trasplante de h\u00edgado, c\u00e1ncer y muerte, a trav\u00e9s de una revisi\u00f3n sistem\u00e1tica s\u00f3lida de datos poblacionales\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/epidemiology-natural-history-and-outcomes-of-primary-sclerosing-cholangitis-a-systematic-review-of-population-based-studies\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5111 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/elife_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"elife_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/elife_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2022\/01\/elife_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-07-13T10:41:00+00:00\">julio 13, 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/lives-saved-with-vaccination-for-10-pathogens-across-112-countries-in-a-pre-covid-19-world\/\">Vidas salvadas con la vacunaci\u00f3n para 10 pat\u00f3genos en 112 pa\u00edses en un mundo anterior a COVID-19<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La vacunaci\u00f3n es una de las intervenciones de salud p\u00fablica m\u00e1s eficaces. Investigamos el impacto de las actividades de vacunaci\u00f3n contra Haemophilus influenzae tipo b, hepatitis B, virus del papiloma humano, encefalitis japonesa, sarampi\u00f3n, Neisseria meningitidis serogrupo A, rotavirus, rub\u00e9ola, Streptococcus pneumoniae y\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/lives-saved-with-vaccination-for-10-pathogens-across-112-countries-in-a-pre-covid-19-world\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4365 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-05-29T21:30:00+00:00\">29 de mayo de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-elimination-in-sweden-progress-challenges-and-opportunities-for-growth-in-the-time-of-covid%e2%80%9019\/\">Eliminaci\u00f3n de la hepatitis C en Suecia: avances, desaf\u00edos y oportunidades de crecimiento en la \u00e9poca de COVID-19<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos En 2014, se evalu\u00f3 la carga del virus de la hepatitis C (VHC) en Suecia para establecer una l\u00ednea de base e informar las intervenciones de salud p\u00fablica. Teniendo en cuenta el panorama cambiante del tratamiento, la prevenci\u00f3n y el tratamiento del VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-elimination-in-sweden-progress-challenges-and-opportunities-for-growth-in-the-time-of-covid%e2%80%9019\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4363 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2021\/04\/EASL_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"EASL_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2021\/04\/EASL_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2021\/04\/EASL_500x500.png\" alt=\"Publication front page\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-04-12T21:26:00+00:00\">12 de abril de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/covid-19-and-global-hcv-elimination-efforts\/\">Esfuerzos globales de eliminaci\u00f3n de COVID-19 y el VHC<\/a><\/h3><p class=\"wpgb-block-5\">Resumen<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/covid-19-and-global-hcv-elimination-efforts\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4369 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-01-30T21:51:00+00:00\">30 de enero de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimating-the-health-impact-of-vaccination-against-ten-pathogens-in-98-low-income-and-middle-income-countries-from-2000-to-2030-a-modelling-study\/\">Estimaci\u00f3n del impacto en la salud de la vacunaci\u00f3n contra diez pat\u00f3genos en 98 pa\u00edses de ingresos bajos y medianos entre 2000 y 2030: un estudio de modelos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes En las \u00faltimas dos d\u00e9cadas se han ampliado los programas de vacunaci\u00f3n infantil en los pa\u00edses de ingresos bajos y medios (PIBM). Cuantificamos el impacto de estos programas en la salud mediante la estimaci\u00f3n de las muertes y los a\u00f1os de vida ajustados por discapacidad (AVAD)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimating-the-health-impact-of-vaccination-against-ten-pathogens-in-98-low-income-and-middle-income-countries-from-2000-to-2030-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4367 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2021\/01\/Lancet-Vol6no3_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology Vol6_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2021\/01\/Lancet-Vol6no3_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2021\/01\/Lancet-Vol6no3_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-01-28T21:37:00+00:00\">28 de enero de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-prevalence-of-hepatitis-c-virus-in-women-of-childbearing-age-in-2019-a-modelling-study\/\">Prevalencia mundial del virus de la hepatitis C en mujeres en edad f\u00e9rtil en 2019: un estudio modelo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes El tratamiento para la infecci\u00f3n por el virus de la hepatitis C (VHC) durante el embarazo a\u00fan no ha sido aprobado; sin embargo, las intervenciones dirigidas espec\u00edficamente a las mujeres, especialmente aquellas en edad f\u00e9rtil (15 a 49 a\u00f1os), podr\u00edan prevenir la transmisi\u00f3n vertical\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-prevalence-of-hepatitis-c-virus-in-women-of-childbearing-age-in-2019-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5115 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2021-01-19T11:06:00+00:00\">19 de enero de 2021<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/progress-towards-hepatitis-c-virus-elimination-in-high-income-countries-an-updated-analysis\/\">Progresos hacia la eliminaci\u00f3n del virus de la hepatitis C en pa\u00edses de ingresos altos: un an\u00e1lisis actualizado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La eliminaci\u00f3n del VHC para 2030, seg\u00fan la definici\u00f3n de la Organizaci\u00f3n Mundial de la Salud (OMS), es alcanzable si se dispone de terapias altamente eficaces. Este estudio informa sobre los avances logrados en el cronograma de eliminaci\u00f3n\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/progress-towards-hepatitis-c-virus-elimination-in-high-income-countries-an-updated-analysis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-5117 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-12-01T11:16:00+00:00\">1 de diciembre de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-cost-effectiveness-of-hepatitis-c-virus-elimination-in-low-and-middle-income-countries\/\">La rentabilidad de la eliminaci\u00f3n del virus de la hepatitis C en pa\u00edses de ingresos bajos y medianos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses\/Territorios: Pa\u00edses de ingresos bajos, Pa\u00edses de ingresos medios<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-cost-effectiveness-of-hepatitis-c-virus-elimination-in-low-and-middle-income-countries\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4339 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lijecbicki_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lijecnicki Vjesnik_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lijecbicki_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lijecbicki_500x500.png\" alt=\"Journal cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-11-12T19:03:00+00:00\">12 de noviembre de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/strategies-to-eliminate-hepatitis-c-in-croatia-a-modelling-study\/\">Estrategias para eliminar la hepatitis C en Croacia, un estudio de modelos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Desde un an\u00e1lisis de 2016 sobre la epidemiolog\u00eda y la carga de enfermedad del VHC en Croacia, el paradigma del tratamiento del VHC ha cambiado sustancialmente. Se eliminaron las restricciones por fibrosis y se triplic\u00f3 el n\u00famero de pacientes tratados. Con\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/strategies-to-eliminate-hepatitis-c-in-croatia-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3082 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/09\/Journal_of_Infection_and_Public_Health_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Infection_and_Public_Health_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/09\/Journal_of_Infection_and_Public_Health_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/09\/Journal_of_Infection_and_Public_Health_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-09-26T16:02:00+00:00\">26 de septiembre de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-tool-to-measure-the-economic-impact-of-hepatitis-b-elimination-a-case-study-in-saudi-arabia\/\">Una herramienta para medir el impacto econ\u00f3mico de la eliminaci\u00f3n de la hepatitis B: un estudio de caso en Arabia Saudita<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes No existe una cura virol\u00f3gica para la infecci\u00f3n por el virus de la hepatitis B (VHB), y las terapias existentes est\u00e1n dise\u00f1adas para controlar la replicaci\u00f3n viral. Nuestro objetivo fue estimar la prevalencia nacional del HBsAg en 2017 y estudiar la\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-tool-to-measure-the-economic-impact-of-hepatitis-b-elimination-a-case-study-in-saudi-arabia\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4358 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-09-01T21:07:00+00:00\">1 de septiembre de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-case-for-simplifying-and-using-absolute-targets-for-viral-hepatitis-elimination-goals\/\">El caso para simplificar y utilizar objetivos absolutos para los objetivos de eliminaci\u00f3n de las hepatitis virales<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La 69.\u00aa Asamblea Mundial de la Salud aprob\u00f3 la Estrategia mundial del sector de la salud contra las hepatitis v\u00edricas, que incluye el objetivo de eliminar la infecci\u00f3n por hepatitis como amenaza para la salud p\u00fablica para 2030. A continuaci\u00f3n, la Asamblea Mundial de la Salud aprob\u00f3 la Estrategia mundial del sector de la salud contra las hepatitis v\u00edricas, que incluye el objetivo de eliminar la infecci\u00f3n por hepatitis como amenaza para la salud p\u00fablica para 2030.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-case-for-simplifying-and-using-absolute-targets-for-viral-hepatitis-elimination-goals\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3086 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/MMWR_Journal_Cover_08.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"MMWR_Journal_Cover_08.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/MMWR_Journal_Cover_08.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/MMWR_Journal_Cover_08.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-08-28T16:16:00+00:00\">28 de agosto de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/progress-toward-hepatitis-b-and-hepatitis-c-elimination-using-a-catalytic-funding-model-tashkent-uzbekistan-december-6-2019-march-15-2020\/\">Progreso hacia la eliminaci\u00f3n de la hepatitis B y la hepatitis C mediante un modelo de financiaci\u00f3n catal\u00edtica - Tashkent, Uzbekist\u00e1n, 6 de diciembre de 2019 a 15 de marzo de 2020<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En 2016, la Organizaci\u00f3n Mundial de la Salud (OMS) estableci\u00f3 como objetivo de eliminaci\u00f3n de la hepatitis una reducci\u00f3n del 90% en la incidencia y del 65% en la mortalidad a nivel mundial para 2030 (1). Los virus de la hepatitis B (VHB) y de la hepatitis C (VHC)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/progress-toward-hepatitis-b-and-hepatitis-c-elimination-using-a-catalytic-funding-model-tashkent-uzbekistan-december-6-2019-march-15-2020\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4342 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-08-10T19:06:00+00:00\">agosto 10, 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modelling-hepatitis-b-virus-infection-and-impact-of-timely-birth-dose-vaccine-a-comparison-of-two-simulation-models\/\">Modelado de la infecci\u00f3n por el virus de la hepatitis B e impacto de la vacuna con dosis de nacimiento oportuna: comparaci\u00f3n de dos modelos de simulaci\u00f3n<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La hepatitis B es una epidemia mundial que requiere iniciativas de vacunaci\u00f3n cuidadosamente orquestadas en regiones geogr\u00e1ficas de endemicidad media a alta para alcanzar los objetivos de eliminaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud para 2030. Este estudio compara dos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modelling-hepatitis-b-virus-infection-and-impact-of-timely-birth-dose-vaccine-a-comparison-of-two-simulation-models\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3084 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/08\/Journal_of_Hepatology_08.2020_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Hepatology_08.2020_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/08\/Journal_of_Hepatology_08.2020_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/08\/Journal_of_Hepatology_08.2020_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-08-07T16:12:00+00:00\">7 de agosto de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/covid-19-on-global-hcv-elimination-efforts\/\">Impacto de COVID-19 en los esfuerzos globales de eliminaci\u00f3n del VHC<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La enfermedad por coronavirus 2019 (COVID-19) ha supuesto una importante presi\u00f3n para los sistemas nacionales de atenci\u00f3n sanitaria en un momento cr\u00edtico en el contexto de la eliminaci\u00f3n de la hepatitis. Se pueden utilizar modelos matem\u00e1ticos para evaluar la\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/covid-19-on-global-hcv-elimination-efforts\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4356 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-07-28T20:59:00+00:00\">28 de julio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-hep-core-policy-score-a-european-hepatitis-c-national-policy-implementation-ranking-based-on-patient-organization-data\/\">La puntuaci\u00f3n de la pol\u00edtica Hep-CORE: una clasificaci\u00f3n europea de implementaci\u00f3n de pol\u00edticas nacionales de hepatitis C basada en datos de organizaciones de pacientes<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Los nuevos tratamientos contra el virus de la hepatitis C (VHC) impulsaron a la Organizaci\u00f3n Mundial de la Salud (OMS) a adoptar en 2016 una estrategia para eliminar el VHC como amenaza para la salud p\u00fablica para 2030. Para lograrlo, se deben adoptar pol\u00edticas clave\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-hep-core-policy-score-a-european-hepatitis-c-national-policy-implementation-ranking-based-on-patient-organization-data\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4353 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Lancet-Vol5no10_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-07-27T20:46:00+00:00\">27 de julio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/do-the-most-heavily-burdened-countries-have-the-right-policies-to-eliminate-viral-hepatitis-b-and-c\/\">\u00bfTienen los pa\u00edses m\u00e1s agobiados las pol\u00edticas adecuadas para eliminar las hepatitis virales B y C?<\/a><\/h3><p class=\"wpgb-block-5\">Resumen \u00bfLos pa\u00edses m\u00e1s afectados tienen las pol\u00edticas adecuadas para eliminar las hepatitis virales B y C? En 2019, una Comisi\u00f3n de Gastroenterolog\u00eda y Hepatolog\u00eda de The Lancet sobre la aceleraci\u00f3n de la eliminaci\u00f3n de las hepatitis virales inform\u00f3 sobre\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/do-the-most-heavily-burdened-countries-have-the-right-policies-to-eliminate-viral-hepatitis-b-and-c\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4350 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Annali_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Annali_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Annali_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/07\/Annali_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-07-12T19:32:00+00:00\">12 de julio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/tailored-screening-and-dedicated-funding-for-direct-acting-antiviral-drugs-how-to-keep-italy-on-the-road-to-hepatitis-c-virus-elimination\/\">Detecci\u00f3n personalizada y financiaci\u00f3n espec\u00edfica para medicamentos antivirales de acci\u00f3n directa: \u00bfc\u00f3mo mantener a Italia en el camino hacia la eliminaci\u00f3n del virus de la hepatitis C?<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La eliminaci\u00f3n del virus de la hepatitis C (VHC) en Italia es un objetivo ambicioso, pero alcanzable. En Italia existe voluntad pol\u00edtica, que aspira a alcanzar los objetivos de eliminaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud (OMS)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/tailored-screening-and-dedicated-funding-for-direct-acting-antiviral-drugs-how-to-keep-italy-on-the-road-to-hepatitis-c-virus-elimination\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3102 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/A_P_and_T_COVER_06.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Alimentary Pharmacology and Therapeutics COVER_06.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/A_P_and_T_COVER_06.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/A_P_and_T_COVER_06.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-06-13T17:06:00+00:00\">13 de junio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/editorial-increasing-burden-of-nonalcoholic-fatty-liver-disease-a-call-to-action-authors-reply\/\">Editorial: aumento de la carga de la enfermedad del h\u00edgado graso no alcoh\u00f3lico: una llamada a la acci\u00f3n. Respuesta de los autores<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Singapur, Corea del Sur<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/editorial-increasing-burden-of-nonalcoholic-fatty-liver-disease-a-call-to-action-authors-reply\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4360 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/Gastroenterology-Clinics-of-North-America_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Gastroenterology Clinics of North America_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/Gastroenterology-Clinics-of-North-America_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/06\/Gastroenterology-Clinics-of-North-America_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-06-12T21:15:00+00:00\">12 de junio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-epidemiology-of-viral-hepatitis\/\">Epidemiolog\u00eda global de la hepatitis viral<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La hepatitis viral (hepatitis A, B, C, D y E) es la principal causa de inflamaci\u00f3n del tejido hep\u00e1tico (hepatitis). La carga de enfermedad asociada con la hepatitis A y E ocurre poco despu\u00e9s de la infecci\u00f3n y\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-epidemiology-of-viral-hepatitis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3089 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"CMAJ_Open_06.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/CMAJ_Open_06.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-06-09T16:23:00+00:00\">9 de junio de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/burden-of-nonalcoholic-fatty-liver-disease-in-canada-2019-2030-a-modelling-study\/\">Carga de la enfermedad del h\u00edgado graso no alcoh\u00f3lico en Canad\u00e1, 2019-2030: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) representan una proporci\u00f3n cada vez mayor de casos de enfermedad hep\u00e1tica, y existe la necesidad de comprender mejor la carga futura de la enfermedad. Utilizamos un modelo\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/burden-of-nonalcoholic-fatty-liver-disease-in-canada-2019-2030-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3095 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/JAMA_Network_Open_06.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"JAMA_Network_Open_06.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/JAMA_Network_Open_06.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/JAMA_Network_Open_06.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-05-01T16:49:00+00:00\">1 de mayo de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/assessment-of-treatment-strategies-to-achieve-hepatitis-c-elimination-in-canada-using-a-validated-model\/\">Evaluaci\u00f3n de las estrategias de tratamiento para lograr la eliminaci\u00f3n de la hepatitis C en Canad\u00e1 mediante un modelo validado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Importancia El logro de la meta de la Organizaci\u00f3n Mundial de la Salud (OMS) de eliminar el virus de la hepatitis C (VHC) para 2030 requerir\u00e1 un aumento de los servicios clave, incluidas las iniciativas de reducci\u00f3n de da\u00f1os, detecci\u00f3n del VHC y tratamiento del VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/assessment-of-treatment-strategies-to-achieve-hepatitis-c-elimination-in-canada-using-a-validated-model\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3080 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-04-28T15:54:00+00:00\">28 de abril de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-tool-to-measure-the-impact-of-inaction-toward-elimination-of-hepatitis-c-a-case-study-in-korea\/\">Una herramienta para medir el impacto de la inacci\u00f3n hacia la eliminaci\u00f3n de la hepatitis C: un estudio de caso en Corea<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos El virus de la hepatitis C (VHC) y sus secuelas representan una fuente importante de carga econ\u00f3mica y social. La introducci\u00f3n de terapias curativas altamente efectivas ha hecho posible la eliminaci\u00f3n del VHC. El estudio utiliz\u00f3 un modelo\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-tool-to-measure-the-impact-of-inaction-toward-elimination-of-hepatitis-c-a-case-study-in-korea\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4348 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-04-02T19:22:00+00:00\">abril 2, 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/optimization-of-hepatitis-c-virus-screening-strategies-by-birth-cohort-in-italy\/\">Optimizaci\u00f3n de las estrategias de detecci\u00f3n del virus de la hepatitis C por cohorte de nacimiento en Italia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Optimizaci\u00f3n de las estrategias de detecci\u00f3n del virus de la hepatitis C por cohorte de nacimiento en Italia Antecedentes y objetivos Se necesitan estrategias de detecci\u00f3n rentables para que la eliminaci\u00f3n del virus de la hepatitis C (VHC) sea una realidad. Determinamos si la cohorte de nacimiento\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/optimization-of-hepatitis-c-virus-screening-strategies-by-birth-cohort-in-italy\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4344 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"BMC_Gastroenterology_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-03-24T19:13:00+00:00\">24 de marzo de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-micro-elimination-approach-to-addressing-hepatitis-c-in-turkey\/\">Un enfoque de microeliminaci\u00f3n para abordar la hepatitis C en Turqu\u00eda<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes En 2016, la OMS aprob\u00f3 la Estrategia mundial del sector de la salud contra las hepatitis v\u00edricas (GHSS), en la que se pide su eliminaci\u00f3n para 2030. Dos a\u00f1os despu\u00e9s, Turqu\u00eda aprob\u00f3 una estrategia para alcanzar los objetivos de la OMS. Este estudio\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-micro-elimination-approach-to-addressing-hepatitis-c-in-turkey\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3093 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Alimentary Pharmacology and Therapeutics Cover_04.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-03-04T16:34:00+00:00\">4 de marzo de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modelling-nafld-disease-burden-in-four-asian-regions-2019-2030\/\">Modelado de la carga de enfermedad de NAFLD en cuatro regiones asi\u00e1ticas, 2019-2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) representan una proporci\u00f3n cada vez mayor de enfermedades hep\u00e1ticas en la regi\u00f3n de Asia y el Pac\u00edfico. Muchas \u00e1reas de la regi\u00f3n est\u00e1n experimentando epidemias de s\u00edndrome metab\u00f3lico entre\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modelling-nafld-disease-burden-in-four-asian-regions-2019-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3091 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-02-26T16:28:00+00:00\">febrero 26, 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-australia-2019-2030\/\">Carga de enfermedad del h\u00edgado graso no alcoh\u00f3lico: Australia, 2019-2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) representan una proporci\u00f3n grande y creciente de la carga de enfermedad hep\u00e1tica a nivel mundial. La carga de NAFLD\/NASH se manifiesta en niveles crecientes de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-australia-2019-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2394 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_01_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology_01_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_01_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_01_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"13\" style=\"color:#0693e3\">Global<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"11\" style=\"color:#00d084\">Pedi\u00e1trico<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2020-01-16T17:32:59+00:00\">16 de enero de 2020<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-prevalence-of-hepatitis-c-virus-in-children-in-2018-a-modelling-study\/\">Prevalencia mundial del virus de la hepatitis C en ni\u00f1os en 2018: un estudio modelo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Las estimaciones de prevalencia del virus de la hepatitis C (VHC) en adultos y grupos de alto riesgo se han publicado ampliamente, pero la carga de la enfermedad en los ni\u00f1os es poco conocida. Los f\u00e1rmacos antivirales de acci\u00f3n directa, que se consideran altamente eficaces\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-prevalence-of-hepatitis-c-virus-in-children-in-2018-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3098 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Swiss_Medical_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2019-12-17T16:50:00+00:00\">17 de diciembre de 2019<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-switzerland-2018-2030\/\">Carga de enfermedad del h\u00edgado graso no alcoh\u00f3lico - Suiza 2018-2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Como resultado de los niveles epid\u00e9micos de obesidad y diabetes mellitus, la enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) contribuir\u00e1n a aumentar la carga de enfermedades relacionadas con el h\u00edgado en Suiza. Un modelo de Markov\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-switzerland-2018-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2414 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Brazilian Journal of Infectious Diseases_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2019-05-27T19:25:00+00:00\">27 de mayo de 2019<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-disease-burden-and-strategies-for-elimination-by-2030-in-brazil-a-mathematical-modeling-approach\/\">Carga de la enfermedad por hepatitis C y estrategias para su eliminaci\u00f3n para 2030 en Brasil. Un enfoque de modelado matem\u00e1tico<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Introducci\u00f3n y objetivo La hepatitis C es un desaf\u00edo clave para la salud p\u00fablica en Brasil. El objetivo de este art\u00edculo fue describir la estrategia brasile\u00f1a para la hepatitis C con el fin de alcanzar la meta de eliminaci\u00f3n propuesta para 2030\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-disease-burden-and-strategies-for-elimination-by-2030-in-brazil-a-mathematical-modeling-approach\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2401 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-11-14T17:57:00+00:00\">14 de noviembre de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/australia-on-track-to-achieve-who-hcv-elimination-targets-following-rapid-initial-daa-treatment-uptake-a-modeling-study\/\">Australia en camino de alcanzar los objetivos de eliminaci\u00f3n del VHC de la OMS tras la r\u00e1pida adopci\u00f3n inicial del tratamiento con AAD: un estudio de modelo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El tratamiento antiviral de acci\u00f3n directa (AAD) subsidiado recientemente se puso a disposici\u00f3n de todos los adultos que viven con hepatitis C cr\u00f3nica (VHC) en Australia. Bas\u00e1ndonos en la r\u00e1pida aceptaci\u00f3n (32.600 personas iniciaron el tratamiento antiviral de acci\u00f3n directa en 2016), estimamos el impacto en\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/australia-on-track-to-achieve-who-hcv-elimination-targets-following-rapid-initial-daa-treatment-uptake-a-modeling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2411 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Nature_Review_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Nature_Reviews_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Nature_Review_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Nature_Review_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-09-03T18:44:00+00:00\">3 de septiembre de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-hepatitis-b-epidemic-and-the-urgent-need-for-cure-preparedness\/\">La epidemia de hepatitis B y la urgente necesidad de prepararse para la cura<\/a><\/h3><p class=\"wpgb-block-5\">Resumen M\u00e1s de 250 millones de personas en todo el mundo padecen infecci\u00f3n cr\u00f3nica por el virus de la hepatitis B (VHB). En este comentario, los miembros de la Coalici\u00f3n Internacional para la Eliminaci\u00f3n del VHB eval\u00faan el entorno normativo actual y la necesidad de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-hepatitis-b-epidemic-and-the-urgent-need-for-cure-preparedness\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2420 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/08\/Addiction_Cover_01.2019_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Addiction_Cover_01.2019_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/08\/Addiction_Cover_01.2019_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/08\/Addiction_Cover_01.2019_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-08-28T19:37:00+00:00\">agosto 28, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-regional-and-country-level-estimates-of-hepatitis-c-virus-infection-among-people-who-have-recently-injected-drugs\/\">Estimaciones a nivel mundial, regional y nacional de la infecci\u00f3n por el virus de la hepatitis C entre personas que se han inyectado drogas recientemente<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos Las personas que se han inyectado drogas recientemente son una poblaci\u00f3n prioritaria en los esfuerzos por lograr la eliminaci\u00f3n del virus de la hepatitis C (VHC). Este estudio estim\u00f3 la prevalencia y el n\u00famero de personas que se han inyectado drogas recientemente\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-regional-and-country-level-estimates-of-hepatitis-c-virus-infection-among-people-who-have-recently-injected-drugs\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2404 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-08-16T18:08:00+00:00\">agosto 16, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hcv-elimination-among-people-who-inject-drugs-modelling-pre-and-post-who-elimination-era\/\">Eliminaci\u00f3n del VHC entre personas que se inyectan drogas. Modelizaci\u00f3n de la era anterior y posterior a la eliminaci\u00f3n de la OMS<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La eliminaci\u00f3n del virus de la hepatitis C (VHC) entre las personas que se inyectan drogas es una inversi\u00f3n costosa, por lo que las estrategias no solo deben centrarse en eliminar la enfermedad, sino tambi\u00e9n en prevenir su resurgimiento.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hcv-elimination-among-people-who-inject-drugs-modelling-pre-and-post-who-elimination-era\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-4336 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-08-10T18:47:00+00:00\">agosto 10, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/forecasting-hepatitis-c-liver-disease-burden-on-real-life-data-does-the-hidden-iceberg-matter-to-reach-the-elimination-goals\/\">Previsi\u00f3n de la carga de la enfermedad hep\u00e1tica por hepatitis C a partir de datos de la vida real. \u00bfImporta el iceberg oculto para alcanzar las metas de eliminaci\u00f3n?<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos Los avances en el tratamiento antiviral de acci\u00f3n directa del VHC han revitalizado las iniciativas de salud p\u00fablica destinadas a identificar a los individuos afectados. Evaluamos el posible impacto de solo los individuos diagnosticados y vinculados a la atenci\u00f3n en la mortalidad general\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/forecasting-hepatitis-c-liver-disease-burden-on-real-life-data-does-the-hidden-iceberg-matter-to-reach-the-elimination-goals\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2407 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Open_Journal_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Open_Journal of Gastroenterology_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Open_Journal_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Open_Journal_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-08-08T18:21:00+00:00\">agosto 8, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-the-epidemiological-landscape-of-chronic-hepatitis-c-in-a-sub-saharan-african-country-what-is-needed-to-achieve-elimination-by-2030-in-burundi\/\">Modelizaci\u00f3n del panorama epidemiol\u00f3gico de la hepatitis C cr\u00f3nica en un pa\u00eds del \u00c1frica subsahariana: lo que se necesita para lograr la eliminaci\u00f3n para 2030 en Burundi<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes El virus de la hepatitis C cr\u00f3nica (VHC) constituye una amenaza cada vez mayor para la salud p\u00fablica internacional, ya que puede tener graves repercusiones en la morbilidad y la mortalidad. Burundi ha hecho poco para abordar la carga de la hepatitis C\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-the-epidemiological-landscape-of-chronic-hepatitis-c-in-a-sub-saharan-african-country-what-is-needed-to-achieve-elimination-by-2030-in-burundi\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2530 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-07-12T15:29:00+00:00\">12 de julio de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/disease-burden-of-hepatitis-c-in-the-austrian-state-of-tyrol-epidemiological-data-and-model-analysis-to-achieve-elimination-by-2030\/\">Carga de enfermedad de la hepatitis C en el estado austriaco de Tirol: datos epidemiol\u00f3gicos y an\u00e1lisis de modelos para lograr la eliminaci\u00f3n para 2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes En 2016, la Organizaci\u00f3n Mundial de la Salud (OMS) y la 69.\u00aa Asamblea Mundial de la Salud aprobaron la primera estrategia mundial del sector de la salud (GHSS) sobre la hepatitis viral con el objetivo de eliminar las infecciones por el virus de la hepatitis C (VHC)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/disease-burden-of-hepatitis-c-in-the-austrian-state-of-tyrol-epidemiological-data-and-model-analysis-to-achieve-elimination-by-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2417 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/07\/Seminars_in_LiverDisease_Cover_07.2018_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Seminars_in_LiverDisease_Cover_07.2018_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/07\/Seminars_in_LiverDisease_Cover_07.2018_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/07\/Seminars_in_LiverDisease_Cover_07.2018_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-07-09T19:32:00+00:00\">julio 9, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-micro-elimination-approach-to-eliminating-hepatitis-c-strategic-and-operational-considerations\/\">El enfoque de micro-eliminaci\u00f3n para eliminar la hepatitis C: consideraciones estrat\u00e9gicas y operativas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La introducci\u00f3n de nuevos tratamientos eficaces contra el virus de la hepatitis C (VHC) impuls\u00f3 a la Organizaci\u00f3n Mundial de la Salud a definir objetivos ambiciosos para eliminar el VHC como amenaza para la salud p\u00fablica para 2030. Para alcanzar este objetivo hay que hacer frente a formidables obst\u00e1culos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-micro-elimination-approach-to-eliminating-hepatitis-c-strategic-and-operational-considerations\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3078 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Journal_of_Hepatology_Cover_10.2018_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Hepatology_Cover_10.2018_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Journal_of_Hepatology_Cover_10.2018_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Journal_of_Hepatology_Cover_10.2018_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-06-08T23:27:00+00:00\">8 de junio de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-nafld-disease-burden-in-china-france-germany-italy-japan-spain-united-kingdom-and-united-states-for-the-period-2016-2030\/\">Modelizaci\u00f3n de la carga de enfermedad de NAFLD en China, Francia, Alemania, Italia, Jap\u00f3n, Espa\u00f1a, Reino Unido y Estados Unidos para el per\u00edodo 2016-2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) son cada vez m\u00e1s una causa de cirrosis y carcinoma hepatocelular a nivel mundial. Se espera que esta carga aumente a medida que aumentan las epidemias de obesidad, diabetes y\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-nafld-disease-burden-in-china-france-germany-italy-japan-spain-united-kingdom-and-united-states-for-the-period-2016-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2422 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Saudi_Journal_of_Gastroenterology_Cover_500x500_V2\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-06-01T19:42:00+00:00\">junio 1, 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030\/\">Carga de la enfermedad por h\u00edgado graso no alcoh\u00f3lico: Arabia Saudita y Emiratos \u00c1rabes Unidos, 2017-2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes\/Objetivo Debido a los niveles epid\u00e9micos de obesidad y diabetes mellitus tipo 2 (DM), la enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) resultante ser\u00e1n factores impulsores de la carga de enfermedad hep\u00e1tica en los pr\u00f3ximos a\u00f1os\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/nonalcoholic-fatty-liver-disease-burden-saudi-arabia-and-united-arab-emirates-2017-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2532 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_02_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology_02_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_02_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Lancet_02_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-03-27T15:42:00+00:00\">27 de marzo de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-prevalence-treatment-and-prevention-of-hepatitis-b-virus-infection-in-2016-a-modelling-study\/\">Prevalencia, tratamiento y prevenci\u00f3n mundial de la infecci\u00f3n por el virus de la hepatitis B en 2016: un estudio de modelado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Colaboradores Colaboradores del Observatorio Polaris: Devin Razavi-Shearer, Ivane Gamkrelidze, Mindie H Nguyen, Ding-Shinn Chen, Pierre Van Damme, Zaigham Abbas, Maheeba Abdulla, Antoine Abou Rached, Danjuma Adda, Inka Aho, Ulus Akarca, Fuad Hasan, Faryal Al Lawati, Khalid Al Naamani, Hamad Ibrahim Al-Ashgar, Seyed M Alavian, Sameer Alawadhi, Agustin Albillos, Said A Al-Busafi, Soo Aleman, Faleh Z Alfaleh, Abdulrahman\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-prevalence-treatment-and-prevention-of-hepatitis-b-virus-infection-in-2016-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2426 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-03-06T19:48:00+00:00\">6 de marzo de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-the-beginning-of-the-end-key-elements-for-successful-european-and-national-strategies-to-eliminate-hcv-in-europe\/\">Hepatitis C: El principio del fin: elementos clave para estrategias europeas y nacionales exitosas para eliminar el VHC en Europa<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n por el virus de la hepatitis C (VHC) es un importante problema de salud p\u00fablica en la Uni\u00f3n Europea (UE). Se estima que 5,6 millones de europeos padecen infecci\u00f3n cr\u00f3nica con una prevalencia muy variable en los distintos pa\u00edses europeos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-the-beginning-of-the-end-key-elements-for-successful-european-and-national-strategies-to-eliminate-hcv-in-europe\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2424 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/01\/Health_Policy_and_Planning_Cover_05.2018_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Health_Policy_and_Planning_Cover_05.2018_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/01\/Health_Policy_and_Planning_Cover_05.2018_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/01\/Health_Policy_and_Planning_Cover_05.2018_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"28\" style=\"color:#2ec4b6\">An\u00e1lisis de pol\u00edticas<\/span><span class=\"wpgb-block-term\" data-id=\"29\" style=\"color:#3E5F8A\">Programa<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2018-01-30T19:45:00+00:00\">30 de enero de 2018<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-investment-case-for-hepatitis-b-and-c-in-south-africa-adaptation-and-innovation-in-policy-analysis-for-disease-program-scale-up\/\">El caso de inversi\u00f3n para la hepatitis B y C en Sud\u00e1frica: adaptaci\u00f3n e innovaci\u00f3n en el an\u00e1lisis de pol\u00edticas para la ampliaci\u00f3n del programa de enfermedades<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Aunque la OMS ha aprobado objetivos mundiales para la eliminaci\u00f3n de la hepatitis, la mayor\u00eda de los pa\u00edses a\u00fan no han establecido programas para la hepatitis B y C, que son responsables de 320 millones de infecciones y m\u00e1s de un mill\u00f3n de muertes al a\u00f1o\u2026.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-investment-case-for-hepatitis-b-and-c-in-south-africa-adaptation-and-innovation-in-policy-analysis-for-disease-program-scale-up\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2558 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><span class=\"wpgb-block-term\" data-id=\"24\" style=\"color:#0d32ff\">NAFLD<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-12-01T16:25:00+00:00\">1 de diciembre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-the-epidemic-of-nonalcoholic-fatty-liver-disease-demonstrates-an-exponential-increase-in-burden-of-disease\/\">Modelar la epidemia de la enfermedad del h\u00edgado graso no alcoh\u00f3lico demuestra un aumento exponencial de la carga de la enfermedad<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La enfermedad del h\u00edgado graso no alcoh\u00f3lico (NAFLD) y la esteatohepatitis no alcoh\u00f3lica (NASH) resultante son muy frecuentes en los Estados Unidos, donde son una causa creciente de cirrosis y carcinoma hepatocelular (CHC) y cada vez m\u00e1s un indicador de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-the-epidemic-of-nonalcoholic-fatty-liver-disease-demonstrates-an-exponential-increase-in-burden-of-disease\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2428 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 300 300\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/39.jpg\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"39\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/39.jpg)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/39.jpg\" alt=\"Publication Title Page\" height=\"300\" width=\"300\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-11-08T19:53:00+00:00\">8 de noviembre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-dynamics-among-intravenous-drug-users-suggest-that-an-annual-treatment-uptake-above-10-would-eliminate-the-disease-by-2030\/\">La din\u00e1mica del virus de la hepatitis C entre los consumidores de drogas intravenosas sugiere que un tratamiento anual superior a 10% eliminar\u00eda la enfermedad para 2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos En Suiza, la prevalencia del virus de la hepatitis C (VHC) entre los consumidores de drogas inyectables ha disminuido gracias a las iniciativas activas de reducci\u00f3n de da\u00f1os y al envejecimiento de la poblaci\u00f3n. Los avances recientes en\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-dynamics-among-intravenous-drug-users-suggest-that-an-annual-treatment-uptake-above-10-would-eliminate-the-disease-by-2030\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2536 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Swiss_Medical_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-11-08T15:49:00+00:00\">8 de noviembre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-dynamics-among-intravenous-drug-users-suggest-that-an-annual-treatment-uptake-above-10-would-eliminate-the-disease-by-2030-2\/\">La din\u00e1mica del virus de la hepatitis C entre los consumidores de drogas intravenosas sugiere que un tratamiento anual superior a 10% eliminar\u00eda la enfermedad para 2030<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos En Suiza, la prevalencia del virus de la hepatitis C (VHC) entre los consumidores de drogas inyectables ha disminuido gracias a las iniciativas activas de reducci\u00f3n de da\u00f1os y al envejecimiento de la poblaci\u00f3n. Los avances recientes en\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-dynamics-among-intravenous-drug-users-suggest-that-an-annual-treatment-uptake-above-10-would-eliminate-the-disease-by-2030-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2548 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-10-30T16:09:00+00:00\">30 de octubre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-infection-disease-burden-volume-4\/\">Estrategias para manejar la carga de morbilidad por infecci\u00f3n por el virus de la hepatitis C \u2014 Volumen 4<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se pronostic\u00f3 que la epidemia del virus de la hepatitis C (VHC) se extender\u00eda hasta 2030 en 17 pa\u00edses de \u00c1frica, Asia, Europa, Am\u00e9rica Latina y Oriente Medio, y se prev\u00e9n intervenciones para lograr la Estrategia mundial del sector de la salud\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-infection-disease-burden-volume-4\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2546 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-10-30T16:05:00+00:00\">30 de octubre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-infections-with-todays-treatment-paradigm-volume-4\/\">La carga de morbilidad presente y futura de las infecciones por el virus de la hepatitis C con el paradigma de tratamiento actual: Volumen 4<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Los factores que influyen en la morbilidad y la mortalidad asociadas con la infecci\u00f3n por el virus de la hepatitis C (VHC) vir\u00e9mica var\u00edan con el tiempo y el lugar, lo que dificulta la comparaci\u00f3n de las estimaciones publicadas. Se desarrollaron modelos para 17 pa\u00edses (Bahr\u00e9in, Bulgaria,\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-infections-with-todays-treatment-paradigm-volume-4\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2544 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-10-30T16:02:00+00:00\">30 de octubre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-in-select-countries-volume-4\/\">Epidemiolog\u00eda hist\u00f3rica del virus de la hepatitis C en pa\u00edses seleccionados-volumen 4<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Debido a la introducci\u00f3n de opciones de tratamiento m\u00e1s nuevas y eficaces, existe una necesidad apremiante de que los responsables de las pol\u00edticas y los funcionarios de salud p\u00fablica desarrollen o adapten estrategias nacionales de control del virus de la hepatitis C (VHC)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-in-select-countries-volume-4\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2540 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-10-30T15:56:00+00:00\">30 de octubre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimating-hcv-disease-burden-volume-4-editorial\/\">Estimaci\u00f3n de la carga de enfermedad por VHC, volumen 4 (editorial)<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El virus de la hepatitis C (VHC) es un importante problema de salud p\u00fablica mundial, con aproximadamente 71 millones de personas infectadas por el VHC y una carga creciente de cirrosis, carcinoma hepatocelular (CHC) y mortalidad relacionada con el h\u00edgado.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimating-hcv-disease-burden-volume-4-editorial\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2550 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/10\/Hepatology_International_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_International_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/10\/Hepatology_International_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/10\/Hepatology_International_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-10-12T16:12:00+00:00\">12 de octubre de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/scenarios-to-manage-the-hepatitis-c-disease-burden-and-associated-economic-impact-of-treatment-in-turkey\/\">Escenarios para gestionar la carga de la enfermedad por hepatitis C y el impacto econ\u00f3mico asociado del tratamiento en Turqu\u00eda<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n por el virus de la hepatitis C (VHC) es un problema de salud importante. El objetivo de este estudio es evaluar la relaci\u00f3n coste-eficacia del tratamiento del VHC y estimar su carga econ\u00f3mica en Turqu\u00eda. M\u00e9todos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/scenarios-to-manage-the-hepatitis-c-disease-burden-and-associated-economic-impact-of-treatment-in-turkey\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2554 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/09\/CDAF_Publication_07.2017_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"CDAF_Publication_07.2017_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/09\/CDAF_Publication_07.2017_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/09\/CDAF_Publication_07.2017_500x500.png\" alt=\"Publication page\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-09-29T16:21:00+00:00\">septiembre 29, 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/colorado-prevalence-and-incidence-of-hepatitis-c-virus-infection-a-modeling-study\/\">Prevalencia e incidencia de la infecci\u00f3n por el virus de la hepatitis C en Colorado: un estudio modelo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n por el virus de la hepatitis C (VHC) es una enfermedad hep\u00e1tica contagiosa que se propaga principalmente a trav\u00e9s del contacto con la sangre y puede variar en gravedad desde una enfermedad leve que desaparece por s\u00ed sola hasta una\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/colorado-prevalence-and-incidence-of-hepatitis-c-virus-infection-a-modeling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2576 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/06\/Acta_Clinica_Belgica_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Clinica_Belgica_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/06\/Acta_Clinica_Belgica_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/06\/Acta_Clinica_Belgica_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"34\" style=\"color:#6f8695\">Comorbilidades<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-06-16T16:53:00+00:00\">16 de junio de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/prevalence-of-non-infectious-comorbidities-in-the-hiv-positive-population-in-belgium-a-multicenter-retrospective-study\/\">Prevalencia de comorbilidades no infecciosas en la poblaci\u00f3n VIH positiva en B\u00e9lgica: un estudio retrospectivo multic\u00e9ntrico<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Objetivos En B\u00e9lgica, once centros de referencia sobre el sida (CRA) y siete laboratorios de referencia sobre el sida diagnostican y tratan a personas VIH positivas y hacen un seguimiento de los pacientes que reciben tratamiento. A medida que se evitan las muertes relacionadas con el sida y la poblaci\u00f3n VIH positiva envejece, las enfermedades no infecciosas\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/prevalence-of-non-infectious-comorbidities-in-the-hiv-positive-population-in-belgium-a-multicenter-retrospective-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2562 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/04\/Global_Hepatitis_Report_Cover_2017_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Global_Hepatitis_Report_Cover_2017_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/04\/Global_Hepatitis_Report_Cover_2017_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/04\/Global_Hepatitis_Report_Cover_2017_500x500.png\" alt=\"Report Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-04-28T16:31:00+00:00\">28 de abril de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimates-of-the-coverage-of-diagnosis-and-treatment-for-hbv-and-hcv-infection-by-who-region-and-income-group-2015\/\">Estimaciones de la cobertura de diagn\u00f3stico y tratamiento de la infecci\u00f3n por VHB y VHC, por regi\u00f3n de la OMS y grupo de ingresos, 2015<\/a><\/h3><p class=\"wpgb-block-5\">Resumen En mayo de 2016, la Asamblea Mundial de la Salud aprob\u00f3 la Estrategia mundial del sector de la salud contra las hepatitis v\u00edricas 2016-2021. La Estrategia hace un llamado a eliminar las hepatitis v\u00edricas como amenaza para la salud p\u00fablica para 2030 (reduciendo\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimates-of-the-coverage-of-diagnosis-and-treatment-for-hbv-and-hcv-infection-by-who-region-and-income-group-2015\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2566 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/National_Academies_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"National_Academies_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/National_Academies_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/National_Academies_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-03-28T16:37:00+00:00\">28 de marzo de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-national-strategy-for-the-elimination-of-hepatitis-b-and-c-phase-two-report\/\">Una estrategia nacional para la eliminaci\u00f3n de la hepatitis B y C: Informe de la segunda fase<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Las hepatitis B y C causan la mayor\u00eda de los casos de hepatitis en los Estados Unidos y el mundo. Ambas enfermedades son responsables de alrededor de un mill\u00f3n de muertes al a\u00f1o y del 78 por ciento de los carcinomas hepatocelulares del mundo...<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-national-strategy-for-the-elimination-of-hepatitis-b-and-c-phase-two-report\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2574 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Lancet_05.2017_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 05.2017_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Lancet_05.2017_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Lancet_05.2017_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-03-15T16:49:00+00:00\">15 de marzo de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-prevalence-and-level-of-intervention-required-to-achieve-the-who-targets-for-elimination-in-the-european-union-by-2030-a-modelling-study\/\">Prevalencia del virus de la hepatitis C y nivel de intervenci\u00f3n necesario para alcanzar los objetivos de eliminaci\u00f3n de la OMS en la Uni\u00f3n Europea para 2030: un estudio de modelo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Colaboradores Colaboradores VHC de la Uni\u00f3n Europea: Homie Razavi, Sarah Robbins, Stefan Zeuzem, Francesco Negro, Maria Buti, Ann-Sofi Duberg, Fran\u00e7oise Roudot-Thoraval, Antonio Craxi, Michael Manns, Rui T Marinho, Bela Hunyady, Massimo Colombo, Soo Alem\u00e1n , Krasimir Antonov, Perttu Arkkila, Kostas Athanasakis, Sarah Blach, Martin Blachier, Antonio J Blasco, Filipe Calinas, Jose L Calleja, Peer B Christensen, Matthew E Cramp, Esther Croes, Robert\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-prevalence-and-level-of-intervention-required-to-achieve-the-who-targets-for-elimination-in-the-european-union-by-2030-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2580 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Nature_Reviews_Cover_HepC_Infection_03.2017_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Nature_Reviews_Cover_HepC_Infection_03.2017_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Nature_Reviews_Cover_HepC_Infection_03.2017_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/03\/Nature_Reviews_Cover_HepC_Infection_03.2017_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-03-02T17:00:00+00:00\">2 de marzo de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-infection\/\">Infecci\u00f3n por el virus de la hepatitis C<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El virus de la hepatitis C (VHC) es un virus ARN hepatotr\u00f3pico que causa da\u00f1o hep\u00e1tico progresivo, que puede derivar en cirrosis hep\u00e1tica y carcinoma hepatocelular. A nivel mundial, entre 64 y 103 millones de personas padecen infecci\u00f3n cr\u00f3nica.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-infection\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2604 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/01\/Medicina_Clinica_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Medicina_Clinica_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2017\/01\/Medicina_Clinica_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2017\/01\/Medicina_Clinica_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-01-31T18:00:00+00:00\">31 de enero de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/elimination-of-hepatitis-c-in-spain-adaptation-of-a-mathematical-model-based-on-the-public-health-strategic-plan-for-addressing-hepatitis-c-in-the-national-health-system\/\">Eliminaci\u00f3n de la hepatitis C en Espa\u00f1a: adaptaci\u00f3n de un modelo matem\u00e1tico basado en el plan estrat\u00e9gico de salud p\u00fablica para el tratamiento de la hepatitis C en el Sistema Nacional de Salud<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Espa\u00f1a<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/elimination-of-hepatitis-c-in-spain-adaptation-of-a-mathematical-model-based-on-the-public-health-strategic-plan-for-addressing-hepatitis-c-in-the-national-health-system\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2584 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2017-01-30T17:06:00+00:00\">30 de enero de 2017<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-burden-and-care-cascade-in-australia-in-the-era-of-interferon-based-treatment\/\">Carga y cascada de atenci\u00f3n de la hepatitis C cr\u00f3nica en Australia en la era del tratamiento con interfer\u00f3n<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo Los reg\u00edmenes antivirales de acci\u00f3n directa sin interfer\u00f3n para la infecci\u00f3n por el virus de la hepatitis C (VHC) han estado disponibles recientemente en Australia, iniciando una nueva era en el manejo cl\u00ednico y de salud p\u00fablica de la infecci\u00f3n por VHC. Este estudio\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-burden-and-care-cascade-in-australia-in-the-era-of-interferon-based-treatment\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2608 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/A-public-health-response-in-the-Americas-Cover-500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"A public health response in the Americas Cover 500&#215;500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/A-public-health-response-in-the-Americas-Cover-500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/A-public-health-response-in-the-Americas-Cover-500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"21\" style=\"color:#933\">VHB<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-12-24T18:05:00+00:00\">24 de diciembre de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-b-and-c-in-the-spotlight-a-public-health-response-in-the-americas-2016\/\">Hepatitis B y C en el centro de atenci\u00f3n: una respuesta de salud p\u00fablica en las Am\u00e9ricas: 2016<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El pasado mes de mayo de 2016, los Estados Miembros de la Organizaci\u00f3n Mundial de la Salud (OMS) aprobaron la primera \u201cEstrategia mundial del sector de la salud contra las hepatitis v\u00edricas 2016-2021\u201d en la 69.\u00aa Asamblea Mundial de la Salud. Esta estrategia contribuir\u00e1 a\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-b-and-c-in-the-spotlight-a-public-health-response-in-the-americas-2016\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2570 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/Lancet_03.2017_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet Gastroenterology and Hepatology 03.2017_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/Lancet_03.2017_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/12\/Lancet_03.2017_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-12-16T16:46:00+00:00\">16 de diciembre de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-prevalence-and-genotype-distribution-of-hepatitis-c-virus-infection-in-2015-a-modelling-study\/\">Prevalencia mundial y distribuci\u00f3n de genotipos de la infecci\u00f3n por el virus de la hepatitis C en 2015: un estudio de modelos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Colaboradores Colaboradores del Observatorio Polaris VHC: Sarah Blach, Stefan Zeuzem, Michael Manns, Ibrahim Altraif, Ann-Sofi Duberg, David H Muljono, Imam Waked, Seyed M Alavian, Mei-Hsuan Lee, Francesco Negro, Faisal Abaalkhail, Ahmed Abdou, Maheeba Abdulla, Antoine Abou Rached, Inka Aho, Ulus Akarca, Imad Al Ghazzawi, Saad Al Kaabi, Faryal Al Lawati, Khalid Al Namaani, Youssif Al Serkal, Said\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-prevalence-and-genotype-distribution-of-hepatitis-c-virus-infection-in-2015-a-modelling-study\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2592 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/11\/Journal_of_Infectious_Disease_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Infectious_Diseases_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/11\/Journal_of_Infectious_Disease_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/11\/Journal_of_Infectious_Disease_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-11-01T17:41:00+00:00\">1 de noviembre de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/historical-trends-in-the-hepatitis-c-virus-epidemics-in-north-america-and-australia\/\">Tendencias hist\u00f3ricas de las epidemias del virus de la hepatitis C en Am\u00e9rica del Norte y Australia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes El an\u00e1lisis evolutivo bayesiano (an\u00e1lisis coalescente) basado en secuencias gen\u00e9ticas se ha utilizado para describir los or\u00edgenes y la propagaci\u00f3n de virus de ARN que mutan r\u00e1pidamente, como la influenza, el \u00e9bola, el virus de la inmunodeficiencia humana (VIH) y la hepatitis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/historical-trends-in-the-hepatitis-c-virus-epidemics-in-north-america-and-australia\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2588 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Journal_of_Hepatology_2016_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Hepatology_2016_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Journal_of_Hepatology_2016_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Journal_of_Hepatology_2016_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-08-09T17:10:00+00:00\">agosto 9, 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-genotype-distribution-of-hepatitis-c-viral-infection-among-people-who-inject-drugs\/\">Distribuci\u00f3n mundial del genotipo de la infecci\u00f3n por el virus de la hepatitis C entre las personas que se inyectan drogas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n por el virus de la hepatitis C despu\u00e9s del consumo de drogas inyectables es muy frecuente. El genotipo m\u00e1s importante que causa la infecci\u00f3n por VHC en los consumidores de drogas inyectables a nivel mundial es el genotipo 1, como sucede en la poblaci\u00f3n general, pero tambi\u00e9n\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-genotype-distribution-of-hepatitis-c-viral-infection-among-people-who-inject-drugs\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2616 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Epidemiology_and_Infection_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Epidemiology_and_Infection_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Epidemiology_and_Infection_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/08\/Epidemiology_and_Infection_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-08-05T18:17:00+00:00\">5 de agosto de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-virus-hcv-burden-in-rhode-island-modelling-treatment-scale-up-and-elimination\/\">Carga del virus de la hepatitis C cr\u00f3nica (VHC) en Rhode Island: modelizaci\u00f3n de la ampliaci\u00f3n y eliminaci\u00f3n del tratamiento<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Utilizamos un modelo de progresi\u00f3n de la enfermedad para predecir el n\u00famero de infecciones vir\u00e9micas, casos cirr\u00f3ticos y muertes relacionadas con el h\u00edgado en el estado de Rhode Island (RI) en cuatro escenarios de tratamiento: (1) paradigma actual de tratamiento del VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-virus-hcv-burden-in-rhode-island-modelling-treatment-scale-up-and-elimination\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2612 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"31\" style=\"color:#ff543d\">Eliminaci\u00f3n<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-07-12T18:11:00+00:00\">12 de julio de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/is-elimination-of-hcv-possible-in-a-country-with-low-diagnostic-rate-and-moderate-hcv-prevalence-the-case-of-greece\/\">\u00bfEs posible la eliminaci\u00f3n del VHC en un pa\u00eds con una tasa de diagn\u00f3stico baja y una prevalencia moderada del VHC ?: El caso de Grecia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo Se prev\u00e9 que el tratamiento de la hepatitis C (VHC) con antivirales de acci\u00f3n directa (AAD) sin interfer\u00f3n (IFN) cambie la carga futura de la enfermedad. El objetivo de este estudio es cuantificar el impacto de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/is-elimination-of-hcv-possible-in-a-country-with-low-diagnostic-rate-and-moderate-hcv-prevalence-the-case-of-greece\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2596 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Saudi_Journal_of_Gastroenterology_Cover_500x500_V2\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/06\/Saudi_Journal_of_Gastroenterology_Cover_500x500_V2.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-07-01T17:48:00+00:00\">1 de julio de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/epidemiology-disease-burden-and-treatment-strategies-of-chronic-hepatitis-c-virus-infections-in-saudi-arabia-in-the-new-treatment-paradigm-shift\/\">Epidemiolog\u00eda, carga de morbilidad y estrategias de tratamiento de las infecciones cr\u00f3nicas por el virus de la hepatitis C en Arabia Saudita en el nuevo cambio de paradigma de tratamiento<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes\/Objetivos Se estima que alrededor de 101.000 personas fueron vir\u00e9micas por el virus de la hepatitis C cr\u00f3nica (VHC) en el Reino de Arabia Saudita (ARS) en 2014; sin embargo, solo se diagnosticaron alrededor de 20%. Nuestro objetivo es\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/epidemiology-disease-burden-and-treatment-strategies-of-chronic-hepatitis-c-virus-infections-in-saudi-arabia-in-the-new-treatment-paradigm-shift\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2527 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatology_Medicine_and_Policy_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_Medicine_and_Policy_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatology_Medicine_and_Policy_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatology_Medicine_and_Policy_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-06-30T15:20:00+00:00\">30 de junio de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/urgent-action-to-fight-hepatitis-c-in-people-who-inject-drugs-in-europe\/\">Acci\u00f3n urgente para combatir la hepatitis C en personas que se inyectan drogas en Europa<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n por el virus de la hepatitis C (VHC) es una de las principales causas de cirrosis hep\u00e1tica y c\u00e1ncer de h\u00edgado y es curable en la mayor\u00eda de las personas. El consumo de drogas inyectables representa actualmente el 80 % de las nuevas infecciones por VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/urgent-action-to-fight-hepatitis-c-in-people-who-inject-drugs-in-europe\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2618 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatitis_Monthly_GenericCover_500x500_v2.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatitis_Monthly_GenericCover_500x500_v2\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatitis_Monthly_GenericCover_500x500_v2.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Hepatitis_Monthly_GenericCover_500x500_v2.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-06-14T18:39:00+00:00\">14 de junio de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/liver-disease-burden-of-hepatitis-c-virus-infection-in-iran-and-the-potential-impact-of-various-treatment-strategies-on-the-disease-burden\/\">Carga de la enfermedad hep\u00e1tica de la infecci\u00f3n por el virus de la hepatitis C en Ir\u00e1n y el impacto potencial de diversas estrategias de tratamiento sobre la carga de la enfermedad<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) se est\u00e1 convirtiendo en la principal causa de enfermedad hep\u00e1tica relacionada con la hepatitis viral en Ir\u00e1n. Objetivos Este estudio estim\u00f3 la carga de enfermedad actual y futura de la infecci\u00f3n por VHC en Ir\u00e1n.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/liver-disease-burden-of-hepatitis-c-virus-infection-in-iran-and-the-potential-impact-of-various-treatment-strategies-on-the-disease-burden\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2523 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-06-01T23:16:00+00:00\">1 de junio de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium\/\">Mitigar la carga del virus de la hepatitis C entre las personas que se inyectan drogas en B\u00e9lgica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos En 2010, se estim\u00f3 que hab\u00eda 10 100 personas que se inyectaban drogas en B\u00e9lgica y 43% (34%-57%) estaban infectadas con el VHC. Comprender la din\u00e1mica de transmisi\u00f3n del VHC en poblaciones de alto riesgo y evaluar el impacto potencial de una mejora en la\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2525 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/05\/World_Journal_of_Hepatology_Article_05.2016_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"World_Journal_of_Hepatology_Article_05.2016_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/05\/World_Journal_of_Hepatology_Article_05.2016_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/05\/World_Journal_of_Hepatology_Article_05.2016_500x500.png\" alt=\"Publication front page\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-05-28T23:23:00+00:00\">28 de mayo de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-infection-in-argentina-burden-of-chronic-disease\/\">Infecci\u00f3n por el virus de la hepatitis C en Argentina: carga de enfermedad cr\u00f3nica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Objetivo Estimar la progresi\u00f3n de la epidemia del virus de la hepatitis C (VHC) y medir la carga de morbilidad y mortalidad relacionadas con el VHC. M\u00e9todos Se utilizaron cohortes definidas por edad y g\u00e9nero para realizar un seguimiento de la poblaci\u00f3n vir\u00e9mica\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-virus-infection-in-argentina-burden-of-chronic-disease\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2602 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"16\" style=\"color:#025669\">PWID<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-04-01T17:58:00+00:00\">1 de abril de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium-2\/\">Mitigar la carga del virus de la hepatitis C entre las personas que se inyectan drogas en B\u00e9lgica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos En 2010, se estim\u00f3 que hab\u00eda 10 100 personas que se inyectaban drogas en B\u00e9lgica y 43% (34%-57%) estaban infectadas con el VHC. Comprender la din\u00e1mica de transmisi\u00f3n del VHC en poblaciones de alto riesgo y evaluar el impacto potencial de una mejor\u00eda en la calidad de vida de los pacientes es una de las claves para una mejor salud y una mejor calidad de vida de los pacientes.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/mitigating-the-burden-of-hepatitis-c-virus-among-people-who-inject-drugs-in-belgium-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2600 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-04-01T17:54:00+00:00\">1 de abril de 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/achieving-who-recommendations-for-hepatitis-c-virus-elimination-in-belgium\/\">Cumplimiento de las recomendaciones de la OMS para la eliminaci\u00f3n del virus de la hepatitis C en B\u00e9lgica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La Organizaci\u00f3n Mundial de la Salud (OMS) public\u00f3 directrices actualizadas para la detecci\u00f3n, la atenci\u00f3n y el tratamiento de pacientes con infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC). M\u00e9todos Se utiliz\u00f3 un modelo de carga de enfermedad por VHC descrito previamente\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/achieving-who-recommendations-for-hepatitis-c-virus-elimination-in-belgium\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2620 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/02\/Lancet_07.2016_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_ Infectious Diseases 07.2016_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2016\/02\/Lancet_07.2016_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2016\/02\/Lancet_07.2016_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"34\" style=\"color:#6f8695\">Comorbilidades<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2016-02-25T18:45:00+00:00\">febrero 25, 2016<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/prevalence-and-burden-of-hcv-co-infection-in-people-living-with-hiv-a-global-systematic-review-and-meta-analysis\/\">Prevalencia y carga de la coinfecci\u00f3n por el VHC en personas que viven con el VIH: una revisi\u00f3n sistem\u00e1tica mundial y un metan\u00e1lisis<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes A nivel mundial, hay 37 millones de personas infectadas por el VIH y 115 millones de personas con anticuerpos contra el virus de la hepatitis C (VHC). Se sabe poco sobre el alcance de la coinfecci\u00f3n por VIH y VHC. Buscamos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/prevalence-and-burden-of-hcv-co-infection-in-people-living-with-hiv-a-global-systematic-review-and-meta-analysis\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2640 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-12-04T20:34:00+00:00\">4 de diciembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-infection-disease-burden-volume-3\/\">Estrategias para manejar la carga de morbilidad por infecci\u00f3n por el virus de la hepatitis C - volumen 3<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se pronostic\u00f3 la epidemia del virus de la hepatitis C (VHC) hasta 2030 en 15 pa\u00edses de Europa, Oriente Medio y Asia, y se consider\u00f3 el impacto relativo de dos escenarios: mayor eficacia del tratamiento manteniendo\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-infection-disease-burden-volume-3\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2638 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-12-04T20:31:00+00:00\">4 de diciembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-infections-with-todays-treatment-paradigm-volume-3\/\">La carga de morbilidad presente y futura de las infecciones por el virus de la hepatitis C con el paradigma de tratamiento actual - volumen 3<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El n\u00famero total, la morbilidad y la mortalidad atribuidas a las infecciones por el virus de la hepatitis C (VHC) vir\u00e9micas cambian con el tiempo, lo que dificulta la comparaci\u00f3n de las estimaciones notificadas en diferentes a\u00f1os. Se desarrollaron modelos para 15 pa\u00edses\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-infections-with-todays-treatment-paradigm-volume-3\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2636 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-12-04T20:27:00+00:00\">4 de diciembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-select-countries-volume-3\/\">Epidemiolog\u00eda hist\u00f3rica del virus de la hepatitis C (VHC) en pa\u00edses seleccionados - volumen 3<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se necesitan datos epidemiol\u00f3gicos detallados y espec\u00edficos de cada pa\u00eds para caracterizar la carga de infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) en todo el mundo. Con las nuevas opciones de tratamiento disponibles, los responsables de las pol\u00edticas y los funcionarios de salud p\u00fablica deben reconsiderar las medidas nacionales\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-select-countries-volume-3\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2634 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-12-04T20:24:00+00:00\">4 de diciembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimating-hcv-disease-burden-volume-3-editorial\/\">Estimaci\u00f3n de la carga de enfermedad por VHC - volumen 3 (editorial)<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Estonia, Hungr\u00eda, Islandia, Indonesia, Ir\u00e1n, Jap\u00f3n, Letonia, L\u00edbano, Lituania, Pakist\u00e1n, Rumania, Arabia Saudita, Eslovenia, Corea del Sur, Emiratos \u00c1rabes Unidos<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimating-hcv-disease-burden-volume-3-editorial\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2622 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Swiss_Medical_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Swiss_Medical_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-12-04T18:53:07+00:00\">4 de diciembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/birth-cohort-distribution-and-screening-for-viraemic-hepatitis-c-virus-infections-in-switzerland\/\">Distribuci\u00f3n de cohortes de nacimiento y detecci\u00f3n de infecciones por el virus de la hepatitis C vir\u00e9mica en Suiza<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Objetivo En Suiza, se han diagnosticado menos de 40% de casos de infecci\u00f3n por el virus de la hepatitis C (VHC). El objetivo de este proyecto era analizar la distribuci\u00f3n de los casos de VHC para desarrollar\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/birth-cohort-distribution-and-screening-for-viraemic-hepatitis-c-virus-infections-in-switzerland\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2632 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/11\/Netherlands_Journal_of_Medicine_Cover_500x500_v2-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Netherlands_Journal_of_Medicine_Cover_500x500_v2\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/11\/Netherlands_Journal_of_Medicine_Cover_500x500_v2-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/11\/Netherlands_Journal_of_Medicine_Cover_500x500_v2-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-11-04T20:15:00+00:00\">4 de noviembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-estimated-future-disease-burden-of-hepatitis-c-virus-in-the-netherlands-with-different-treatment-paradigms\/\">La carga estimada de morbilidad futura del virus de la hepatitis C en los Pa\u00edses Bajos con diferentes paradigmas de tratamiento<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La prevalencia de la infecci\u00f3n por el virus de la hepatitis C (VHC) en los Pa\u00edses Bajos es baja (prevalencia de anti-VHC 0,22%). El tratamiento oral con antivirales de acci\u00f3n directa (AAD) es tolerable y eficaz, pero costoso. Nuestro an\u00e1lisis proyect\u00f3\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-estimated-future-disease-burden-of-hepatitis-c-virus-in-the-netherlands-with-different-treatment-paradigms\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2626 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><time class=\"wpgb-block-2\" datetime=\"2015-09-11T19:00:00+00:00\">11 de septiembre de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-comparative-risk-assessment-of-79-behavioural-environmental-and-occupational-and-metabolic-risks-or-clusters-of-risks-in-188-countries-1990-2013-a-systematic-analysi\/\">Evaluaci\u00f3n comparativa de riesgos a nivel mundial, regional y nacional de 79 riesgos conductuales, ambientales, ocupacionales y metab\u00f3licos o grupos de riesgos en 188 pa\u00edses, 1990-2013: un an\u00e1lisis sistem\u00e1tico para el Estudio de la carga mundial de enfermedades de 2013<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes El estudio Carga mundial de enfermedades, lesiones y factores de riesgo 2013 (GBD 2013) es el primero de una serie de actualizaciones anuales del GBD. La cuantificaci\u00f3n de los factores de riesgo, en particular los factores de riesgo modificables,\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-comparative-risk-assessment-of-79-behavioural-environmental-and-occupational-and-metabolic-risks-or-clusters-of-risks-in-188-countries-1990-2013-a-systematic-analysi\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2630 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><time class=\"wpgb-block-2\" datetime=\"2015-08-28T20:09:00+00:00\">28 de agosto de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-disability-adjusted-life-years-dalys-for-306-diseases-and-injuries-and-healthy-life-expectancy-hale-for-188-countries-1990-2013-quantifying-the-epidemiological-tra\/\">A\u00f1os de vida ajustados por discapacidad (AVAD) a nivel mundial, regional y nacional para 306 enfermedades y lesiones y esperanza de vida saludable (HALE) para 188 pa\u00edses, 1990-2013: cuantificaci\u00f3n de la transici\u00f3n epidemiol\u00f3gica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes El Estudio de la Carga Mundial de Enfermedades 2013 (GBD 2013) tiene como objetivo reunir todos los datos epidemiol\u00f3gicos disponibles utilizando un marco de medici\u00f3n coherente, m\u00e9todos de estimaci\u00f3n estandarizados y fuentes de datos transparentes para permitir comparaciones de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-disability-adjusted-life-years-dalys-for-306-diseases-and-injuries-and-healthy-life-expectancy-hale-for-188-countries-1990-2013-quantifying-the-epidemiological-tra\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2628 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-08-24T20:05:00+00:00\">24 de agosto de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/interferon-based-hepatitis-c-antiviral-treatment-outcomes-may-be-predicted-by-alanine-aminotransferase-levels\/\">Los resultados del tratamiento antiv\u00edrico de la hepatitis C basado en interfer\u00f3n pueden predecirse mediante los niveles de alanina aminotransferasa<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La disminuci\u00f3n o normalizaci\u00f3n de los niveles de enzimas hep\u00e1ticas durante el tratamiento se observa a menudo despu\u00e9s del inicio del tratamiento antiviral contra el virus de la hepatitis C (VHC) basado en interfer\u00f3n y puede reflejar la respuesta al tratamiento y la disminuci\u00f3n de los niveles de ARN del VHC (1,2). Durante el tratamiento\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/interferon-based-hepatitis-c-antiviral-treatment-outcomes-may-be-predicted-by-alanine-aminotransferase-levels\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2642 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Alimentary Pharmacology and Therapeutics Cover_04.2020_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/03\/A_P_and_T_Cover_04.2020_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-07-22T20:36:00+00:00\">22 de julio de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-in-egypt-the-future-impact-of-highly-effective-therapies\/\">Carga econ\u00f3mica de la hepatitis C en Egipto: el impacto futuro de terapias altamente efectivas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La prevalencia de la infecci\u00f3n por el virus de la hepatitis C (VHC) en Egipto es la m\u00e1s alta del mundo, pero no se ha cuantificado la carga econ\u00f3mica total. Es necesario comprender mejor los costos y el impacto de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-in-egypt-the-future-impact-of-highly-effective-therapies\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2646 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"PlosOne_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/04\/PlosOne_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-06-24T20:48:00+00:00\">24 de junio de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modeling-the-health-and-economic-burden-of-hepatitis-c-virus-in-switzerland\/\">Modelizaci\u00f3n de la carga econ\u00f3mica y sanitaria del virus de la hepatitis C en Suiza<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C es una de las principales causas de enfermedad hep\u00e1tica en Suiza y conlleva una carga econ\u00f3mica significativa. En la actualidad, solo se aplican estrategias conservadoras para mitigar la carga de la hepatitis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modeling-the-health-and-economic-burden-of-hepatitis-c-virus-in-switzerland\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2644 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-06-04T20:43:00+00:00\">4 de junio de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-disease-burden-of-hepatitis-c-in-belgium-an-update-of-a-realistic-disease-control-strategy\/\">La carga de enfermedad de la hepatitis C en B\u00e9lgica: una actualizaci\u00f3n de una estrategia realista de control de enfermedades<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Este manuscrito sirve como actualizaci\u00f3n de los documentos de posici\u00f3n publicados en 2014 basados en los datos epidemiol\u00f3gicos disponibles sobre el virus de la hepatitis C (VHC) en B\u00e9lgica. M\u00e9todos Bas\u00e1ndose en el est\u00e1ndar de atenci\u00f3n actual (2015: 900\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-disease-burden-of-hepatitis-c-in-belgium-an-update-of-a-realistic-disease-control-strategy\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2624 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Brazilian Journal of Infectious Diseases_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2020\/11\/Brazilian-Journal_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-06-04T18:56:00+00:00\">4 de junio de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/disease-burden-of-chronic-hepatitis-c-in-brazil\/\">Carga de enfermedad de la hepatitis C cr\u00f3nica en Brasil<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n por el virus de la hepatitis C es una de las principales causas de cirrosis, carcinoma hepatocelular y trasplante de h\u00edgado. El objetivo de este estudio fue estimar la progresi\u00f3n de la enfermedad por el virus de la hepatitis C y la carga de morbilidad\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/disease-burden-of-chronic-hepatitis-c-in-brazil\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2648 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/05\/Medical_Journal_of_Australia_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Medical_Journal_of_Australia_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/05\/Medical_Journal_of_Australia_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/05\/Medical_Journal_of_Australia_Cover_500x500.png\" alt=\"Publication front page\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-05-18T20:55:00+00:00\">18 de mayo de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hcv-infected-patients-need-access-now-to-new-direct-acting-antiviral-agents-to-avert-liver-related-deaths\/\">Los pacientes infectados por el VHC necesitan acceso ahora a nuevos agentes antivirales de acci\u00f3n directa para evitar muertes relacionadas con el h\u00edgado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Australia<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hcv-infected-patients-need-access-now-to-new-direct-acting-antiviral-agents-to-avert-liver-related-deaths\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2678 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/01\/European_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"European_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/01\/European_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/01\/European_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-01-05T22:25:00+00:00\">5 de enero de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/forecasting-the-disease-burden-of-chronic-hepatitis-c-virus-in-poland\/\">Previsi\u00f3n de la carga de morbilidad del virus de la hepatitis C cr\u00f3nica en Polonia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C afecta a 200.000 personas en Polonia; sin embargo, pocas son conscientes de su enfermedad (30.000 diagnosticadas) y a\u00fan menos reciben tratamiento (2.490 en 2014). Este an\u00e1lisis\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/forecasting-the-disease-burden-of-chronic-hepatitis-c-virus-in-poland\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2656 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-01-05T21:11:00+00:00\">5 de enero de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-hcv-infection-disease-burden-volume-2\/\">Estrategias para manejar la carga de morbilidad por infecci\u00f3n por el virus de la hepatitis C (VHC) - volumen 2<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se pronostic\u00f3 la epidemia del virus de la hepatitis C (VHC) hasta 2030 en 15 pa\u00edses y se consider\u00f3 el impacto relativo de dos escenarios: (i) mayor eficacia del tratamiento manteniendo constante la poblaci\u00f3n tratada y (ii)\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-hcv-infection-disease-burden-volume-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2654 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-01-05T21:08:00+00:00\">5 de enero de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-hcv-infections-with-todays-treatment-paradigm-volume-2\/\">La carga de morbilidad presente y futura de las infecciones por el virus de la hepatitis C (VHC) con el paradigma de tratamiento actual - volumen 2<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La morbilidad y la mortalidad atribuibles a la infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) est\u00e1n aumentando en muchos pa\u00edses a medida que la poblaci\u00f3n infectada envejece. Se desarrollaron modelos para 15 pa\u00edses con el fin de cuantificar y caracterizar la poblaci\u00f3n vir\u00e9mica\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-hcv-infections-with-todays-treatment-paradigm-volume-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2652 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-01-05T21:05:00+00:00\">5 de enero de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-select-countries-volume-2\/\">Epidemiolog\u00eda hist\u00f3rica del virus de la hepatitis C (VHC) en pa\u00edses seleccionados - volumen 2<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) es una de las principales causas de morbilidad y mortalidad relacionadas con el h\u00edgado. En muchos pa\u00edses, faltan datos epidemiol\u00f3gicos completos que son cruciales para implementar medidas de control de enfermedades\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-select-countries-volume-2\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2650 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2015-01-05T21:00:00+00:00\">5 de enero de 2015<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/estimates-on-hcv-disease-burden-worldwide-filling-the-gaps\/\">Estimaciones sobre la carga de enfermedad por VHC en todo el mundo: colmar las brechas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La hepatitis C es causada por la infecci\u00f3n con el virus de la hepatitis C (VHC) y representa una importante carga de salud mundial. La infecci\u00f3n persistente por VHC puede provocar una enfermedad hep\u00e1tica progresiva con el desarrollo de cirrosis hep\u00e1tica\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/estimates-on-hcv-disease-burden-worldwide-filling-the-gaps\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2666 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/New_Zealand_Medical_Journal_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"New_Zealand_Medical_Journal_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/New_Zealand_Medical_Journal_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/New_Zealand_Medical_Journal_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-12-19T21:43:00+00:00\">19 de diciembre de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/improved-treatment-on-disease-burden-of-chronic-hepatitis-c-in-new-zealand\/\">Impacto de un tratamiento mejorado sobre la carga de morbilidad de la hepatitis C cr\u00f3nica en Nueva Zelanda<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La hepatitis C cr\u00f3nica es una causa importante de insuficiencia hep\u00e1tica, c\u00e1ncer de h\u00edgado y muertes relacionadas con el h\u00edgado en Nueva Zelanda. Aunque estas complicaciones se pueden prevenir mediante la erradicaci\u00f3n del VHC, la tasa de aceptaci\u00f3n actual del tratamiento es de &lt;1% por a\u00f1o.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/improved-treatment-on-disease-burden-of-chronic-hepatitis-c-in-new-zealand\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2668 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/Scandinavian_Journal_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Scandinavian_Journal_of Gastroenterology Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/Scandinavian_Journal_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/12\/Scandinavian_Journal_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-12-17T21:52:00+00:00\">17 de diciembre de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-future-disease-burden-of-hepatitis-c-virus-infection-in-sweden-and-the-impact-of-different-treatment-strategies\/\">La carga de morbilidad futura de la infecci\u00f3n por el virus de la hepatitis C en Suecia y el impacto de las diferentes estrategias de tratamiento<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Objetivo Recientemente se han introducido nuevos antivirales de acci\u00f3n directa (AAD) muy eficaces contra el virus de la hepatitis C (VHC). Se desconoce si estos medicamentos aliviar\u00e1n el aumento previsto de la carga de enfermedades hep\u00e1ticas en Suecia, en parte debido a los altos costos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-future-disease-burden-of-hepatitis-c-virus-infection-in-sweden-and-the-impact-of-different-treatment-strategies\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3029 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-09-29T21:41:00+00:00\">29 de septiembre de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/response-to-letter-to-the-editor-strategies-to-reduce-hcv-disease-burden-and-hcv-transmission-need-different-models-as-what-works-for-end%e2%80%90stage-liver-disease-may-not-work-for-hcv-prevalence\/\">Respuesta a la carta al editor: Las estrategias para reducir la carga de enfermedad por VHC y la transmisi\u00f3n del VHC necesitan modelos diferentes, ya que lo que funciona para la enfermedad hep\u00e1tica en etapa terminal puede no funcionar para la prevalencia del VHC: un comentario sobre los resultados presentados en el n\u00famero especial de JVH<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Australia, Austria, B\u00e9lgica, Brasil, Canad\u00e1, Rep\u00fablica Checa, Dinamarca, Egipto, Inglaterra, Francia, Alemania, Portugal, Espa\u00f1a, Suecia, Suiza, Turqu\u00eda<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/response-to-letter-to-the-editor-strategies-to-reduce-hcv-disease-burden-and-hcv-transmission-need-different-models-as-what-works-for-end%e2%80%90stage-liver-disease-may-not-work-for-hcv-prevalence\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2676 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"BMC_Gastroenterology_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/BMC_Gastroenterology_Cover_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-08-07T22:19:00+00:00\">7 de agosto de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/modelling-the-impact-of-improving-screening-and-treatment-of-chronic-hepatitis-c-virus-infection-on-future-hepatocellular-carcinoma-rates-and-liver-related-mortality\/\">Modelizaci\u00f3n del impacto de la mejora de la detecci\u00f3n y el tratamiento de la infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C en las tasas futuras de carcinoma hepatocelular y la mortalidad relacionada con el h\u00edgado<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Se espera que la carga social, cl\u00ednica y econ\u00f3mica impuesta por las complicaciones de la infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC), incluidas la cirrosis y el carcinoma hepatocelular (CHC), aumente en las pr\u00f3ximas d\u00e9cadas.\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/modelling-the-impact-of-improving-screening-and-treatment-of-chronic-hepatitis-c-virus-infection-on-future-hepatocellular-carcinoma-rates-and-liver-related-mortality\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2674 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/08\/Journal_of_Gastroenterology_and_Hepatology_Cover_2014_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-08-04T22:16:00+00:00\">4 de agosto de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/enhanced-antiviral-treatment-efficacy-and-uptake-in-preventing-the-rising-burden-of-hepatitis-c-related-liver-disease-and-costs-in-australia\/\">Mayor eficacia y aceptaci\u00f3n del tratamiento antiviral para prevenir la carga creciente de la enfermedad hep\u00e1tica relacionada con la hepatitis C y los costos en Australia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) es una causa importante de enfermedad hep\u00e1tica avanzada y muertes relacionadas con el h\u00edgado en Australia. Nuestro objetivo fue describir la carga de la infecci\u00f3n por VHC y considerar\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/enhanced-antiviral-treatment-efficacy-and-uptake-in-preventing-the-rising-burden-of-hepatitis-c-related-liver-disease-and-costs-in-australia\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2670 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/07\/Journal_of_Hepatology_Cover_11.2014_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal_of_Hepatology_Cover_11.2014_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/07\/Journal_of_Hepatology_Cover_11.2014_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/07\/Journal_of_Hepatology_Cover_11.2014_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-07-30T22:02:00+00:00\">30 de julio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection\/\">Epidemiolog\u00eda mundial y distribuci\u00f3n de genotipos de la infecci\u00f3n por el virus de la hepatitis C<\/a><\/h3><p class=\"wpgb-block-5\">Resumen El tratamiento de la infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) tiene el potencial de cambiar significativamente en los pr\u00f3ximos a\u00f1os, ya que los reg\u00edmenes terap\u00e9uticos est\u00e1n evolucionando r\u00e1pidamente. Sin embargo, la carga de la infecci\u00f3n cr\u00f3nica no ha\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-epidemiology-and-genotype-distribution-of-the-hepatitis-c-virus-infection\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2692 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-07-22T21:37:00+00:00\">22 de julio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-incidence-and-mortality-for-hiv-tuberculosis-and-malaria-during-1990-2013-a-systematic-analysis-for-the-global-burden-of-disease-study-2013\/\">Incidencia y mortalidad mundial, regional y nacional por VIH, tuberculosis y malaria durante 1990-2013: un an\u00e1lisis sistem\u00e1tico para el Estudio de la carga mundial de morbilidad 2013<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Los datos recientes indican que los tratamientos antivirales totalmente orales para la hepatitis C cr\u00f3nica ser\u00e1n una realidad en un futuro cercano. Se espera que los reg\u00edmenes totalmente orales, que reemplazar\u00e1n a las terapias basadas en interfer\u00f3n, sean m\u00e1s tolerables, m\u00e1s eficaces\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/global-regional-and-national-incidence-and-mortality-for-hiv-tuberculosis-and-malaria-during-1990-2013-a-systematic-analysis-for-the-global-burden-of-disease-study-2013\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2690 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/ClinicoEconomics_and_Outcomes_Research_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"ClinicoEconomics_and_Outcomes_Research_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/ClinicoEconomics_and_Outcomes_Research_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/ClinicoEconomics_and_Outcomes_Research_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-19T22:55:00+00:00\">19 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/health-policy-model-long-term-predictive-results-associated-with-the-management-of-hepatitis-c-virus-induced-diseases-in-italy\/\">Modelo de pol\u00edtica sanitaria: resultados predictivos a largo plazo asociados con el tratamiento de las enfermedades inducidas por el virus de la hepatitis C en Italia<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Actualmente no existen estudios epidemiol\u00f3gicos espec\u00edficos a nivel nacional que representen a toda la poblaci\u00f3n italiana. Este estudio tiene como objetivo describir la carga epidemiol\u00f3gica y econ\u00f3mica que generar\u00e1 el VHC en los pr\u00f3ximos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/health-policy-model-long-term-predictive-results-associated-with-the-management-of-hepatitis-c-virus-induced-diseases-in-italy\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2680 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/Arab_Journal_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Arab_Journal_of Gastroenterology Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/Arab_Journal_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2014\/06\/Arab_Journal_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-06T22:32:00+00:00\">6 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-current-and-future-disease-burden-of-chronic-hepatitis-c-virus-infection-in-egypt\/\">La carga de morbilidad actual y futura de la infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C en Egipto<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Egipto<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-current-and-future-disease-burden-of-chronic-hepatitis-c-virus-infection-in-egypt\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2688 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-04T22:50:00+00:00\">4 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/current-and-future-health-and-economic-impact-of-hepatitis-c-in-belgium\/\">Impacto sanitario y econ\u00f3mico actual y futuro de la hepatitis C en B\u00e9lgica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivos del estudio La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) es un grave problema de salud mundial que afecta a 150 millones de personas en todo el mundo. Aunque las tasas de infecci\u00f3n est\u00e1n disminuyendo, se espera que la poblaci\u00f3n envejezca y progrese\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/current-and-future-health-and-economic-impact-of-hepatitis-c-in-belgium\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2686 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-04T22:45:00+00:00\">4 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-disease-burden-of-hepatitis-c-in-belgium-development-of-a-realistic-disease-control-strategy\/\">La carga de morbilidad de la hepatitis C en B\u00e9lgica: desarrollo de una estrategia realista de control de enfermedades<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Pronto estar\u00e1n disponibles nuevos agentes antivirales directos (AAD), con una respuesta viral sostenida (RVS) m\u00e1s alta, menos efectos secundarios y mayor cumplimiento. Nuestro objetivo fue evaluar diferentes estrategias realistas para controlar el aumento proyectado\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-disease-burden-of-hepatitis-c-in-belgium-development-of-a-realistic-disease-control-strategy\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2684 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-04T22:40:00+00:00\">4 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-epidemiology-in-belgium\/\">Epidemiolog\u00eda de la hepatitis C en B\u00e9lgica<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La carga de infecci\u00f3n por el virus de la hepatitis C (VHC) es significativa y est\u00e1 aumentando con el envejecimiento de la poblaci\u00f3n. Los resultados de un estudio de modelado que incluy\u00f3 a B\u00e9lgica, junto con muchos otros pa\u00edses, se publicaron\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-epidemiology-in-belgium\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2682 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Acta_Gastro_Enterologica_Belgica_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/06\/Acta_Gastro_Enterologica_Belgica_Generic_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-06-04T22:36:00+00:00\">4 de junio de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/innovative-strategies-for-hepatitis-c-in-belgium-integrating-treatment-efficacy-public-disease-burden-and-healthcare-costs\/\">Estrategias innovadoras para la hepatitis C en B\u00e9lgica que integran la eficacia del tratamiento, la carga de morbilidad p\u00fablica y los costes sanitarios<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: B\u00e9lgica<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/innovative-strategies-for-hepatitis-c-in-belgium-integrating-treatment-efficacy-public-disease-burden-and-healthcare-costs\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2672 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/08\/Canadian_Journal_of_Gastroenterology_and_Hepatology_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-05-05T22:10:00+00:00\">5 de mayo de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/burden-of-disease-and-cost-of-chronic-hepatitis-c-infection-in-canada\/\">Carga de enfermedad y costo de la infecci\u00f3n cr\u00f3nica por hepatitis C en Canad\u00e1<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) es una de las principales causas de cirrosis, carcinoma hepatocelular y trasplante hep\u00e1tico. Objetivo Calcular la carga de enfermedad y los costos relacionados con el VHC desde una perspectiva canadiense. M\u00e9todos\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/burden-of-disease-and-cost-of-chronic-hepatitis-c-infection-in-canada\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2664 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-05-05T21:40:00+00:00\">5 de mayo de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-hcv-disease-burden\/\">Estrategias para manejar la carga de morbilidad por el virus de la hepatitis C (VHC)<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se prev\u00e9 que el n\u00famero de infecciones por el virus de la hepatitis C (VHC) disminuya, mientras que aumentar\u00e1 el de las personas con enfermedad hep\u00e1tica avanzada. Se utiliz\u00f3 un enfoque de modelado para pronosticar dos escenarios de tratamiento: (i) el impacto de\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/strategies-to-manage-hepatitis-c-virus-hcv-disease-burden\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2662 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-05-05T21:22:00+00:00\">5 de mayo de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-hcv-infection-with-todays-treatment-paradigm\/\">La carga de morbilidad presente y futura de la infecci\u00f3n por el virus de la hepatitis C (VHC) con el paradigma de tratamiento actual<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Se espera que la carga de enfermedad del virus de la hepatitis C (VHC) aumente a medida que la poblaci\u00f3n infectada envejece. Se utiliz\u00f3 un enfoque de modelado para estimar el n\u00famero total de infecciones vir\u00e9micas, diagnosticadas, tratadas y nuevas\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-present-and-future-disease-burden-of-hepatitis-c-virus-hcv-infection-with-todays-treatment-paradigm\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2660 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-05-05T21:18:00+00:00\">5 de mayo de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-selected-countries\/\">Epidemiolog\u00eda hist\u00f3rica del virus de la hepatitis C (VHC) en pa\u00edses seleccionados<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) es un indicador principal de enfermedad hep\u00e1tica. Est\u00e1n surgiendo nuevas opciones de tratamiento y es necesario caracterizar la epidemiolog\u00eda y la carga de morbilidad del VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/historical-epidemiology-of-hepatitis-c-virus-hcv-in-selected-countries\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-2658 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"12\" style=\"color:#cc59d2\">Modelado<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2014-05-05T21:14:00+00:00\">5 de mayo de 2014<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-disease-burden-and-strategies-to-manage-the-burden-guest-editors-mark-thursz-gregory-dore-and-john-ward\/\">Carga de la enfermedad de la hepatitis C y estrategias para manejar la carga (Editores invitados Mark Thruz, Gregory Dore y John Ward)<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n cr\u00f3nica por el virus de la hepatitis C (VHC) provoca fibrosis hep\u00e1tica, cirrosis y carcinoma hepatocelular (CHC). El reciente proyecto Carga mundial de morbilidad estim\u00f3 que en 2010, de los 170 millones de personas que viv\u00edan con VHC cr\u00f3nica,\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-disease-burden-and-strategies-to-manage-the-burden-guest-editors-mark-thursz-gregory-dore-and-john-ward\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3032 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2013-11-12T21:45:00+00:00\">12 de noviembre de 2013<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-new-paradigm-of-hepatitis-c-therapy-integration-of-oral-therapies-into-best-practices\/\">El nuevo paradigma de la terapia contra la hepatitis C: integraci\u00f3n de las terapias orales en las mejores pr\u00e1cticas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Colaboradores Reuni\u00f3n Nuevo Paradigma de Terapia para el VHC Participantes: Nezam H Afdhal, Rachel Baden, Cynthia Beam, Julie Krop, Clifford Brass, David Brumley, Laurent Castera, Daniel Church, Alfred DeMaria Jr, Kevin Cranston, Lynda Dee, Arnold Doyle, Julia Engstrom-Melnyk, Michael Fried, Camilla Graham, Michael Wong, William Guyer, John G McHutchison, Joe Steele, William Symonds, Ira M Jacobson, Alain Litwin, Anthony\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-new-paradigm-of-hepatitis-c-therapy-integration-of-oral-therapies-into-best-practices\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3037 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/10\/Unitaid_2013_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Unitaid_2013_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2013\/10\/Unitaid_2013_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/10\/Unitaid_2013_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"34\" style=\"color:#6f8695\">Comorbilidades<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2013-10-01T22:03:00+00:00\">1 de octubre de 2013<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hepatitis-c-medicines-and-diagnostics-in-the-context-of-hiv-hcv-co-infection-a-scoping-report\/\">Medicamentos y diagn\u00f3sticos de la hepatitis C en el contexto de la coinfecci\u00f3n por VIH \/ VHC: informe de alcance<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La Estrategia 2013-2016 de UNITAID incluye el tratamiento del VIH\/SIDA y las coinfecciones como uno de los seis objetivos estrat\u00e9gicos. Este informe exploratorio se centra en las cuestiones, los desaf\u00edos y las oportunidades relacionadas con uno de los problemas m\u00e1s importantes del VIH\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hepatitis-c-medicines-and-diagnostics-in-the-context-of-hiv-hcv-co-infection-a-scoping-report\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3041 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 499 499\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/08\/JAMA_Generic_Cover-e1606777837213.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"JAMA_Generic_Cover\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2013\/08\/JAMA_Generic_Cover-e1606777837213.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/08\/JAMA_Generic_Cover-e1606777837213.png\" alt=\"Journal Cover\" height=\"499\" width=\"499\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><time class=\"wpgb-block-2\" datetime=\"2013-08-14T22:05:00+00:00\">14 de agosto de 2013<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-state-of-us-health-1990-2010-burden-of-diseases-injuries-and-risk-factors\/\">El estado de la salud de EE. UU., 1990-2010: carga de enfermedades, lesiones y factores de riesgo<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Importancia Comprender los principales problemas de salud en los Estados Unidos y c\u00f3mo est\u00e1n cambiando con el tiempo es fundamental para fundamentar las pol\u00edticas sanitarias nacionales. Objetivos Medir la carga de enfermedades, lesiones y\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-state-of-us-health-1990-2010-burden-of-diseases-injuries-and-risk-factors\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3045 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Hepatology_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/05\/Hepatology_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2013-05-06T22:17:00+00:00\">6 de mayo de 2013<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-virus-hcv-disease-burden-and-cost-in-the-united-states\/\">Carga y costo de la enfermedad cr\u00f3nica por el virus de la hepatitis C (VHC) en los Estados Unidos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen La infecci\u00f3n por el virus de la hepatitis C (VHC) es una de las principales causas de cirrosis, carcinoma hepatocelular y trasplante de h\u00edgado. Una mejor comprensi\u00f3n de la progresi\u00f3n de la enfermedad por VHC y el costo asociado puede ayudar a la comunidad m\u00e9dica a controlar la enfermedad por VHC\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/chronic-hepatitis-c-virus-hcv-disease-burden-and-cost-in-the-united-states\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3049 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 499 499\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/03\/JEGH_cover_500x500-e1606778349787.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Epidemiology and Global Health_cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2013\/03\/JEGH_cover_500x500-e1606778349787.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2013\/03\/JEGH_cover_500x500-e1606778349787.png\" alt=\"Journal Cover\" height=\"499\" width=\"499\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2013-03-19T22:24:00+00:00\">19 de marzo de 2013<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/hcv-infection-prevalence-in-a-population-recruited-at-health-centers-in-jordan\/\">Prevalencia de la infecci\u00f3n por VHC en una poblaci\u00f3n reclutada en centros de salud de Jordania<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Jordania carece de datos estad\u00edsticos sobre la prevalencia del VHC. Objetivo Determinar la prevalencia del VHC en \u00e1reas seleccionadas de Jordania (norte, centro y sur de Jordania). M\u00e9todos Se seleccion\u00f3 una muestra aleatoria de 700 pacientes\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/hcv-infection-prevalence-in-a-population-recruited-at-health-centers-in-jordan\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3058 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2012-12-15T22:44:00+00:00\">15 de diciembre de 2012<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/years-lived-with-disability-ylds-for-1160-sequelae-of-289-diseases-and-injuries-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease-study-2010\/\">A\u00f1os vividos con discapacidad (AVD) por 1160 secuelas de 289 enfermedades y lesiones 1990-2010: un an\u00e1lisis sistem\u00e1tico para el Estudio de la carga mundial de enfermedades 2010<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Las consecuencias no fatales para la salud de las enfermedades y las lesiones son un factor crucial a considerar en la promoci\u00f3n y el seguimiento de la salud individual y de la poblaci\u00f3n. Los estudios de la Carga Mundial de Enfermedades (GBD, por sus siglas en ingl\u00e9s) realizados en 1990 y 2000\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/years-lived-with-disability-ylds-for-1160-sequelae-of-289-diseases-and-injuries-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease-study-2010\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3056 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><time class=\"wpgb-block-2\" datetime=\"2012-12-15T22:38:00+00:00\">15 de diciembre de 2012<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-comparative-risk-assessment-of-burden-of-disease-and-injury-attributable-to-67-risk-factors-and-risk-factor-clusters-in-21-regions-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease\/\">Una evaluaci\u00f3n comparativa del riesgo de la carga de morbilidad y lesi\u00f3n atribuible a 67 factores de riesgo y grupos de factores de riesgo en 21 regiones, 1990-2010: un an\u00e1lisis sistem\u00e1tico para el Estudio de la Carga Mundial de Enfermedad 2010<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La cuantificaci\u00f3n de la carga de morbilidad causada por diferentes riesgos aporta informaci\u00f3n para la prevenci\u00f3n, ya que proporciona una descripci\u00f3n de la p\u00e9rdida de salud diferente de la que ofrece un an\u00e1lisis enfermedad por enfermedad. No se ha realizado una revisi\u00f3n completa de la carga de morbilidad mundial\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-comparative-risk-assessment-of-burden-of-disease-and-injury-attributable-to-67-risk-factors-and-risk-factor-clusters-in-21-regions-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3053 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Lancet_Generic_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2015\/09\/Lancet_Generic_500x500-1.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"36\" style=\"color:#ff2607\">VIH<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2012-12-15T22:30:00+00:00\">15 de diciembre de 2012<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/disability-adjusted-life-years-dalys-for-291-diseases-and-injuries-in-21-regions-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease-study-2010\/\">A\u00f1os de vida ajustados por discapacidad (AVAD) para 291 enfermedades y lesiones en 21 regiones, 1990-2010: un an\u00e1lisis sistem\u00e1tico para el Estudio de la carga mundial de enfermedades 2010<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes Medir la carga de enfermedades y lesiones en las poblaciones requiere una m\u00e9trica compuesta que capture tanto la mortalidad prematura como la prevalencia y gravedad de la mala salud. El estudio de 1990 sobre la Carga Mundial de Enfermedades propuso una escala de vida ajustada por discapacidad\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/disability-adjusted-life-years-dalys-for-291-diseases-and-injuries-in-21-regions-1990-2010-a-systematic-analysis-for-the-global-burden-of-disease-study-2010\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3060 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2012\/05\/JME_2012_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Medical Economics_2012_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2012\/05\/JME_2012_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2012\/05\/JME_2012_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2012-05-24T22:51:00+00:00\">24 de mayo de 2012<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-associated-diseases-europe-asia-pacific-and-the-americas\/\">Carga econ\u00f3mica de las enfermedades asociadas a la hepatitis C: Europa, Asia Pac\u00edfico y las Am\u00e9ricas<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes A nivel mundial, el virus de la hepatitis C (VHC) infecta a aproximadamente el 31% de la poblaci\u00f3n. El objetivo de este estudio fue revisar los trabajos publicados y determinar los costos m\u00e9dicos directos de las enfermedades asociadas con la infecci\u00f3n por VHC a nivel mundial\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-associated-diseases-europe-asia-pacific-and-the-americas\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3064 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Journal of Viral Hepatitis_GenericCover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2018\/11\/JVH_GenericCover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"32\" style=\"color:#00a1a1\">Impacto econ\u00f3mico<\/span><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-12-18T22:58:00+00:00\">18 de diciembre de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-associated-diseases-in-the-united-states\/\">Carga econ\u00f3mica de las enfermedades asociadas a la hepatitis C en los Estados Unidos<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Hay aproximadamente 100 medicamentos en desarrollo para tratar la hepatitis C. Durante la pr\u00f3xima d\u00e9cada, estar\u00e1n disponibles varias terapias nuevas. Es necesario comprender bien el costo de las secuelas de la hepatitis C\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/economic-burden-of-hepatitis-c-associated-diseases-in-the-united-states\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3070 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-07-12T23:06:00+00:00\">12 de julio de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/applying-a-system-approach-to-forecast-the-total-hepatitis-c-virus-infected-population-size-model-validation-using-us-data\/\">Aplicaci\u00f3n de un enfoque de sistema para pronosticar el tama\u00f1o total de la poblaci\u00f3n infectada por el virus de la hepatitis C: validaci\u00f3n del modelo utilizando datos de EE. UU.<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La infecci\u00f3n por el virus de la hepatitis C (VHC) se asocia a una enfermedad hep\u00e1tica cr\u00f3nica y progresiva. Su epidemiolog\u00eda global a\u00fan no est\u00e1 bien determinada y su impacto se enfrentar\u00e1 a una mayor carga en los pr\u00f3ximos a\u00f1os.<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/applying-a-system-approach-to-forecast-the-total-hepatitis-c-virus-infected-population-size-model-validation-using-us-data\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3066 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-07-12T23:05:28+00:00\">12 de julio de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/the-global-health-burden-of-hepatitis-c-virus-infection\/\">La carga sanitaria mundial de la infecci\u00f3n por el virus de la hepatitis C<\/a><\/h3><p class=\"wpgb-block-5\">Resumen No hay resumen disponible. Pa\u00edses: Brasil, Argentina, Puerto Rico, M\u00e9xico, Estados Unidos, Canad\u00e1, Reino Unido, Alemania, Suiza, Suecia, Grecia, Francia, Espa\u00f1a, Italia, Rumania, Rusia, China, Jap\u00f3n, Taiw\u00e1n, Vietnam, Tailandia, Australia, India, Pakist\u00e1n, Israel, Arabia Saudita,\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/the-global-health-burden-of-hepatitis-c-virus-infection\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3076 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-06-08T23:21:00+00:00\">8 de junio de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-systematic-review-of-hepatitis-c-virus-epidemiology-in-asia-australia-and-egypt\/\">Una revisi\u00f3n sistem\u00e1tica de la epidemiolog\u00eda del virus de la hepatitis C en Asia, Australia y Egipto<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes La pandemia de hepatitis C se ha estudiado y caracterizado sistem\u00e1ticamente en Am\u00e9rica del Norte y Europa, pero este importante problema de salud p\u00fablica no ha recibido la misma atenci\u00f3n en otras regiones. Objetivo El objetivo de este estudio es\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-systematic-review-of-hepatitis-c-virus-epidemiology-in-asia-australia-and-egypt\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3074 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-06-08T23:17:00+00:00\">8 de junio de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/a-systematic-review-of-hepatitis-c-virus-epidemiology-in-europe-canada-and-israel\/\">Una revisi\u00f3n sistem\u00e1tica de la epidemiolog\u00eda del virus de la hepatitis C en Europa, Canad\u00e1 e Israel<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo Las decisiones sobre cuestiones de salud p\u00fablica dependen de datos epidemiol\u00f3gicos fiables. Se realiz\u00f3 una revisi\u00f3n exhaustiva de la literatura para recopilar datos espec\u00edficos de cada pa\u00eds sobre factores de riesgo, prevalencia, n\u00famero de personas diagnosticadas...<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/a-systematic-review-of-hepatitis-c-virus-epidemiology-in-europe-canada-and-israel\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article><article class=\"wpgb-card wpgb-card-7 wpgb-post-3072 wpgb-card-hidden\" data-col=\"1\" data-row=\"1\" data-format=\"standard\"><div class=\"wpgb-card-wrapper\"><div class=\"wpgb-card-inner\"><div class=\"wpgb-card-media wpgb-scheme-light\"><svg data-ratio style=\"padding-top:100%\" viewbox=\"0 0 500 500\" aria-hidden=\"true\"><\/svg><div class=\"wpgb-card-media-thumbnail\"><a href=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" tabindex=\"-1\" class=\"wpgb-handle-lb wpgb-lightbox\" data-type=\"image\" data-rel=\"2\" data-title=\"Liver_International_Generic_Cover_500x500\" title=\"Agrandar foto\"><div style=\"background-image:url(https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png)\"><\/div><noscript><img loading=\"lazy\" decoding=\"async\" class=\"wpgb-noscript-img\" src=\"https:\/\/cdafound.org\/wp-content\/uploads\/2011\/07\/Liver_International_Generic_Cover_500x500.png\" alt=\"Journal Cover\" height=\"500\" width=\"500\"><\/noscript><\/a><\/div><\/div><div class=\"wpgb-card-content wpgb-scheme-dark\"><div class=\"wpgb-card-body\"><div class=\"wpgb-block-1 cdaf-wggb-block-terms-list\"><span class=\"wpgb-block-term\" data-id=\"10\" style=\"color:#5e4eb6\">VHC<\/span><\/div><time class=\"wpgb-block-2\" datetime=\"2011-06-08T23:11:00+00:00\">8 de junio de 2011<\/time><h3 class=\"wpgb-block-3\"><a href=\"https:\/\/cdafound.org\/es\/trends-and-projections-of-hepatitis-c-virus-epidemiology-in-latin-america\/\">Tendencias y proyecciones de la epidemiolog\u00eda del virus de la hepatitis C en Am\u00e9rica Latina<\/a><\/h3><p class=\"wpgb-block-5\">Resumen Antecedentes y objetivo El prop\u00f3sito de la presente investigaci\u00f3n es proporcionar un an\u00e1lisis de trabajos previos sobre la epidemiolog\u00eda de la infecci\u00f3n por el virus de la hepatitis C (VHC) de seis pa\u00edses de Am\u00e9rica Latina,\u2026<\/p><\/div><div class=\"wpgb-card-footer\"><a class=\"wpgb-block-4 button\" href=\"https:\/\/cdafound.org\/es\/trends-and-projections-of-hepatitis-c-virus-epidemiology-in-latin-america\/\">Leer m\u00e1s<\/a><\/div><\/div><\/div><\/div><\/article>\t\t<\/div>\n\t<\/div>\n\t<div class=\"wpgb-loader\">\n\t<div class=\"wpgb-loader-9\">\n\t\t<div><\/div><div><\/div>\t<\/div>\n<\/div>\n<\/div>\n\t<\/div>\n\t\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":24,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"subtheme":[],"class_list":["post-2705","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/pages\/2705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/comments?post=2705"}],"version-history":[{"count":9,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/pages\/2705\/revisions"}],"predecessor-version":[{"id":8912,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/pages\/2705\/revisions\/8912"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/media?parent=2705"}],"wp:term":[{"taxonomy":"subtheme","embeddable":true,"href":"https:\/\/cdafound.org\/es\/wp-json\/wp\/v2\/subtheme?post=2705"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}